Coated medical products, and methods for preparing and using same
Coated medical products with strategically applied polymeric coatings on porous substrates address the need for enhanced performance by creating stratified structures, achieving improved tissue interaction and application efficacy through controlled preparation methods.
Patent Information
- Application Number
- PCT/US2024/027693
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-03
- Filing Date
- 2024-05-03
- Publication Date
- 2024-11-07
AI Technical Summary
There is a need for improved medical products with porous substrates coated with polymeric substances that provide unique configurations and enhanced performance properties, such as adhesive, lubricious, or bioactive properties, and for alternative methods to prepare and use these coated products effectively.
The development of coated medical products featuring a porous sheet substrate with strategically applied polymeric coatings, where the coatings are distributed to create stratified structures with distinct composition domains, and methods involving controlled application and drying processes to achieve specific surface properties and conformational features.
The solution enables the creation of medical products with enhanced adhesive, lubricious, or bioactive properties, facilitating improved interaction with patient tissue and providing effective performance in medical applications, while the methods ensure precise control over coating distribution and substrate interaction.
Smart Images

Figure US2024027693_07112024_PF_FP_ABST
Abstract
Description
[0001] COATED MEDICAL PRODUCTS, AND METHODS FOR PREPARING AND USING SAME
[0002] BACKGROUND
[0003] Aspects of the present disclosure relate to medical devices incorporating a porous sheet substrate such as an extracellular matrix material that carries a coating material including one or more polymeric substances, and to methods for their preparation and use.
[0004] As further background, a variety of medical products include a porous substrate that is coated with one or more polymeric substances. As examples, the coating may provide adhesive properties, anti-tissue-adhesion properties, lubriciousness, and / or bioactivity to the product, among other things. Both the substances used in the coating and the techniques to by which those substances are combined with a substrate can impact the final form of the coating and of the coated product as a whole, as well as performance properties thereof.
[0005] Needs exist for improved and alternative medical products that include a porous substrate that carries a coating material including one or more polymeric substances, and improved and alternative methods for their preparation and use. In some aspects, the present disclosure is addressed to these needs.
[0006] SUMMARY
[0007] In certain aspects, the present disclosure relates to coated medical products that include a porous sheet substrate and a polymeric coating material, where the substrate and coating material are combined to provide unique product configurations that can be beneficial in use of the coated medical products. In some forms, the coating material is distributed over and within the porous sheet substrate to provide a stratified structure having compositionally distinct domains through a thickness of the coated medical product from a first face to a second face opposite the first face.
[0008] Accordingly, in some embodiments herein, provided are coated medicai products that include a porous sheet substrate having a first side surface, a second side surface opposite the first side surface and a thickness between the first side surface and the second side surface. The products include a first coating including one or more polymeric substances at the first side surface and penetrating only partially through the thickness of the porous sheet substrate, and a second coating including the one or more polymeric substances and penetrating only partially through the thickness of the porous sheet substrate.
[0009] In other embodiments herein, provided are coated medical products including a porous sheet substrate having a first side surface, a second side surface opposite the first side surface, and a thickness extending from the first side surface to the second side surface. The products include a first coating including one or more polymeric substances on the first side surface and a second coating including one or more polymeric substances on the second side surface. The first coating and the second coating can have been separately applied and / or can be distinct from one another. The coated medical products can be in a flat condition absent externally applied force. In beneficial forms, the polymeric substance(s) of the first coating include at least one hydrogel-forming polymeric substance and / or the polymeric substance(s) of the second coating include at least one hydrogel-forming polymeric substance. In stili other embodiments herein, provided are coated medical products that include a porous sheet substrate having a first side surface, a second side surface opposite the first side surface, and a thickness extending from the first side surface to the second side surface. The products include a first coating including one or more polymeric substances on the first side surface. The products further include a second coating including one or more polymeric substances on the second side surface, wherein the second coating and the first coating are not segments of a single, uniform coating formed on the porous sheet substrate, for example where the second coating and the first coating are distinct and have been separately formed on the porous sheet substrate. The coated medical products, absent externally applied force, are desirably in a flat condition.
[0010] In still further embodiments herein, provided are coated medical products that include a porous sheet substrate having a first side surface, a second side surface opposite the first side surface, and a thickness extending from the first side surface to the second side surface. The products also include a polymeric coating material carried by the porous sheet substrate, the coating material including one or more polymeric substances. The coating material is configured to become lubricious on wetting with water and further: (i) penetrates only partially through the thickness of the substrate; and / or (ii) has a first coating surface that is contoured to the first side surface of the substrate; and / or (iii) has a first coating surface formed by self-coalescing of the polymeric substance(s) during drying of a liquid coating medium including the polymeric substance(s) while horizontal to gravity; and / or (I v) has at least 60% by dry weight, or optionally at least 70% by dry weight, of the polymeric substance(s) of the coating material occurring externa! of the substrate.
[0011] In still further embodiments herein, provided are coated medical products including a porous sheet substrate including a plurality of layers of decelluiarized extracellular matrix material laminated together, the substrate having a first side surface, a second side surface, and a thickness occurring between the first side surface and the second side surface. Polymeric coating material is carried by the porous sheet substrate. The polymeric coating material includes a plurality of polymeric substances in admixture, and the plurality of polymeric substances Includes at least two hydrogel-forming polymeric substances. The polymeric coating material includes an Internalized coating material portion positioned within the porous sheet substrate and an externalized coating material portion positioned external of the porous sheet substrate. The externalized coating material portion includes at least 60% by dry weight of the plurality of polymeric substances of the polymeric coating material.
[0012] In additional aspects herein, the present disclosure relates to methods for preparing coated medical products, where a substrate and a polymeric coating material are combined under controlled conditions to provide unique product configurations that can be beneficial in use of the coated medical products. In some forms, the controlled conditions provide unique distributions of the polymeric coating material relative to the substrate of the product, unique conformational features to the product, and / or unique surface properties to the product.
[0013] Accordingly, in some embodiments herein, provided are methods for preparing a coated extracellular matrix material that include first applying a first liquid coating medium containing one or more polymeric substances to a first side surface of a porous sheet substrate so that the liquid medium penetrates pores of the porous sheet substrate only partially through a thickness of the porous sheet substrate between the first side surface of the porous sheet substrate and a second side surface of the porous sheet substrate opposite the first side surface. The methods also include first treating the first liquid coating medium to form a first coating including the one or more polymeric substances of the first liquid coating medium, the first coating providing amounts of the polymeric substance(s) of the first liquid coating medium at the first side surface and penetrating only partially through the thickness of the porous sheet substrate. Further included is a step of second applying a second liquid coating medium containing one or more polymeric substances to the second side surface of the porous sheet substrate so that the second liquid coating medium penetrates pores of the porous sheet substrate only partially through the thickness of the porous sheet substrate. As well, the methods include second treating the second liquid coating medium to form a second coating including the one or more polymeric substances of the second liquid coating medium, the second coating providing amounts of the polymeric substance(s) of the second liquid coating medium at the second side surface and penetrating only partially through the thickness of the porous sheet substrate. The first treating and second treating preferably include drying the first liquid coating medium and the second liquid coating medium, respectively.
[0014] In additional embodiments herein, provided are methods for preparing a coated medical product that include first applying a first liquid coating medium containing one or more polymeric substances to a first side surface of a flat, dried porous sheet substrate, so as to form a layer of the first liquid coating medium. The methods also include first drying the first liquid coating medium by exposure to a first drying atmosphere to form a first coating including the one or more polymeric substances of the first liquid coating medium, where the first drying is conducted while the porous sheet substrate is secured in a flat condition with a surface of the layer of the first liquid coating medium freely exposed to the drying atmosphere.
[0015] In further embodiments herein, provided are methods for preparing a coated medical product that include first applying a first liquid coating medium containing one or more polymeric substances to a first side surface of a porous sheet substrate, where the first side surface to which the first liquid coating medium is applied is enclosed within a frame circumferentially surrounding the first side surface. The methods also include first treating the first liquid coating medium to form a first coating including the one or more polymeric substances of the first liquid coating medium. The first treating desirably includes drying. In beneficial forms, the frame compresses the porous sheet substrate to create a compressed substrate periphery that can be less porous than the substrate region underlying the first side surface to which the first liquid coating medium is applied, and / or the first treating is conducted while the porous sheet substrate is secured in a flat condition by the frame, and / or the first treating includes first drying while a surface of a layer of the applied first liquid coating medium is freely exposed to a first drying atmosphere. As well, corresponding steps can be conducted in respect of a second side surface of the porous sheet substrate opposite the first side surface, to form a second coating including one or more polymeric substances of a second liquid coating medium.
[0016] In still further embodiments herein, provided are methods for preparing a coated medical product that include applying a volume of a first liquid coating medium containing one or more polymeric substances to a first side surface of a porous sheet substrate mechanically held in a flat, horizontal condition (for example by a frame), and allowing the volume of the first liquid coating medium to self-level to gravity. The methods also include treating the volume of the first liquid coating medium to form a first coating including the one or more polymeric substances of the first liquid coating medium. The treating desirably includes drying. In beneficial forms, the applying is conducted by gravitational flow of the first liquid coating medium onto the first side surface of the porous sheet substrate and gravitationally-generated spreading and leveling of the first liquid coating medium, e.g. without contact of the applied volume of the first liquid coating medium with any mechanical element that exerts a force that spreads the first liquid coating medium on the porous sheet substrate or promotes penetration of the first liquid coating medium into the porous sheet substrate. The treating can include drying while a surface of a layer of the applied first liquid coating medium is freely exposed to a drying atmosphere and / or while the substrate is mechanically held in a flat, horizontal condition (for example by a frame) and / or while a substrate periphery that surrounds the first side surface to which the first liquid coating medium has been applied is compressed (for example by a frame). As weil, corresponding steps can be conducted in respect of a second side surface of the porous sheet substrate opposite the first side surface, to form a second coating including one or more polymeric substances of a second liquid coating medium.
[0017] Still further aspects herein relate to methods for patient treatment using coated medical products described herein and / or prepared using methods described herein. Additional embodiments herein, as well as beneficial features thereof, will be apparent to persons skilled in the field from the descriptions herein.
[0018] BRIEF DESCRIPTiON OF THE FIGURES
[0019] In order that the disclosure may be well understood, there will now be described various forms thereof, given by way of example, reference being made to the accompanying drawings. The components in each of the drawings may not necessarily be drawn to scale, rather emphasis is placed upon illustrating the principles of the invention. Moreover, like referenced numerals in different drawings designate corresponding or similar components or elements.
[0020] FIG. 1 provides an exploded view of one embodiment of a frame and porous sheet substrate combination useful for preparing a coated medical product.
[0021] FIG. 2 provides a top perspective view of the assembled frame and porous sheet substrate combination depicted in FIG. 1.
[0022] FIG. 3 provides a cross sectional view of the combination of FIG. 2.
[0023] FIG. 4 provides a cross-sectional view showing the layup construct shown in FIG. 3 after gravity-directed application, spreading and leveling of a first liquid coating medium on a first side surface of the porous sheet substrate.
[0024] FIG. 5 provides a cross-sectional view showing the layup construct shown in FIG. 4 after treating to form a first coating from the first liquid coating medium.
[0025] FIG. 6 provides a cross-sectional view showing the combination shown in FIG. 5 after inversion and then gravity-directed application, spreading and leveling of a second liquid coating medium on a second side surface of the porous sheet substrate opposite the first side surface.
[0026] FIG. 7 provides a cross-sectional view showing the layup construct shown in FIG. 6 after treating to form a second coating from the second liquid coating medium. FIG. 8 provides a cross-sectional view of a coated medical product cut from the coated porous sheet substrate shown in FIG. 7 and including the first coating and the second coating.
[0027] FIG. 9 provides a cross-sectional view of one embodiment of a multilaminate porous sheet substrate for use in preparing a coated medical product in accordance with the present disclosure.
[0028] FIG. 10 provides a cross-sectional view showing the multilaminate porous sheet substrate of FIG. 9 after application of a volume of a first liquid coating medium to a first side surface thereof.
[0029] FIG. 11 provides a cross-sectional view of the multilarrnnate porous sheet substrate of FIG. 10 after treating to form a first coating.
[0030] FIG. 12 provides a cross-sectional view showing the construct of FIG. 11 after inversion and application of a volume of a second liquid coating medium to a second side surface thereof.
[0031] FIG. 13 provides a cross-sectional view showing the construct of FIG. 12 after treating to form a second coating.
[0032] FIG. 14 provides a cross-sectional view showing the multilaminate porous sheet substrate of FIG. 9 after application of a volume of a first liquid coating medium to a first side surface thereof and deep penetration of amounts of the first liquid coating medium into the substrate.
[0033] FIG. 15 provides a cross-sectional view of the multilaminate porous sheet substrate of FIG. 14 after treating to form a first coating. FIG. 16 provides a cross-sectional view showing the construct of FIG. 15 after inversion and application of a volume of a second liquid coating medium to a second side surface thereof and deep penetration of amounts of the second liquid coating medium into the substrate to mix with substance(s) of the first liquid coating medium.
[0034] FIG. 17 provides a cross-sectional view showing the construct of FIG. 16 after treating to form another embodiment of a coated medical product of the present disclosure with a stratified compositional structure including an intermediate stratum containing a mixture of polymeric substances resultant of a first coating application and a second coating application.
[0035] FIG. 18 provides a cross-sectional view of one embodiment of a coated medical product conformed against a cylindrical shaping surface useful for post-coating- processing to impart a new shape memory to the coated medical product.
[0036] FIG. 19 provides a perspective view of the reshaped coated medical product shown in FIG. 18.
[0037] FIG. 20 provides a cross-sectional view of another embodiment of a coated medical product conformed against a cylindrical shaping surface useful for post-coatingprocessing to impart a new shape memory to the coated medical product.
[0038] FIG. 21 provides a perspective view of the reshaped coated medical product shown in FIG. 20.
[0039] FIG. 22 provides a schematic illustration of one embodiment of a medical product according to the present disclosure including a sterile barrier package in which is sterilely contained a coated medical product of the present disclosure. DETAILED DESCRIPTION
[0040] Reference will now be made to certain embodiments, some of which are illustrated in the drawings, and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the disclosure herein is thereby intended. Any alterations and further modifications in the described embodiments and any further applications of the principles as described herein are contemplated as would normally occur to a person skilled in the art to which the embodiments relate.
[0041] As disclosed above, certain embodiments of the present disclosure relate to methods for preparing coated medical products, coated medical products, and methods for using coated medical products. The coated medical products include a porous sheet substrate and polymeric coating material carried by the porous sheet substrate, for example including at least a first coating including one or more polymeric substances applied to the porous sheet substrate and in some forms also a second coating including one or more polymeric substances applied to the porous sheet substrate.
[0042] FIGs. 1-8 are illustrative of methods for preparing coated medical products and coated medical products that may be obtained thereby. Referring particularly to FIG. 1 and FIG. 2, shown is a porous sheet substrate 20 to be coated, a frame including a first frame component 100 cooperable with a second frame component 102, and an insert plate 104. Porous sheet substrate 20 includes a first side surface 22 and a second side surface 24 opposite the first side surface 22. Porous sheet substrate 20 also Includes first, second, third and fourth edges 26, 28, 30 and 32, respectively. It will be understood that while substrate 20 shown is rectangular including four edges 26,28,30,32, other shapes including polygonal shapes having multiple edges or circular or ovoid shapes having a continuous edge, may also be used.
[0043] The frame components 100 and 102 define respective openings 106 and 108. Openings 106 and 108 are bounded and closed on all sides by walls of the frame components 100 and 102, and the openings 106 and 108 can be of the same shape and dimensions as one another, as illustrated. The walls of the frame components 100 and 102 define inner wall surfaces 110 and 112, respectively, that in the assembled state with the porous sheet substrate 20 extend transversely to and outward (e.g. upward or downward) from the side surfaces of the substrate 20, The inner wall surfaces 110 and 112 can thereby form respective liq u id-pooling volumes bounded by circumscribing by inner wall surfaces 110 and 112 in combination, respectively, with the first side surface 22 and second side surface 24 of the porous sheet substrate 20, The first side surface 22 and second side surface 24 of such an assembled combination can in sequence be positioned facing upward and horizontal with respect to gravity for sequential coating operations in which liquid coating mediums are applied and allowed to self-level to gravity, for example as discussed further hereinbelow.
[0044] In the assembled state, the frame components 100 and 102 have aligned surfaces that face each other and contact the first side surface 22 and second side surface 24 of the substrate 20, respectively. The frame components 100 and 102 may be held together under compression, with the compression for example provided by magnets embedded in or otherwise associated with one or both components 100 and 102 (e.g. with magnet-to-magnet attraction and / or with magnet-to-metal attraction in the case of metallic frame(s)). Other mechanism for holding the frame components 100 and 102 together, potentially under compression, may also be used, including for example mechanical clamps, pins extending through corresponding openings in frame components 100 and 102, and others. When held together under compression frame components 100 and 102 in some forms may compress and thereby reduce the porosity of and / or provide resistance against thickness expansion and consequent increase in the porosity of, regions of the porous sheet substrate 20 aligned with the wall structures of components 100 and 102 that are compressed toward one another from the opposite sides of the substrate 20. This can create a compressed peripheral band of the porous sheet substrate 20 that surrounds an inner region of the porous substrate 20 that occurs within the openings 106 and 108 and that bounds in part the pooling volumes as discuss above on either side of the assembled frame / substrate combination. The compressed band of the porous substrate 20 can exhibit a lower tendency to absorb a liquid coating medium as compared to the inner region of the porous sheet substrate 20, which can facilitate maintenance of liquid coating medium applied within the defined pooling volumes upon and within the inner region of the porous sheet substrate (e.g. preventing or diminishing any wicking of the liquid coating medium into the surrounding compressed, less porous band). This in turn can facilitate the formation of a dried coating for which the polymeric substance(s) of the applied liquid coating medium remain upon and within the inner regions of the substrate 20 that occur within the openings 106 and 108.
[0045] In one manner of preparing an assembly as shown in FIG. 2, the porous sheet substrate 20 can be positioned upon and pinned to frame component 102 around a periphery of porous sheet substrate 20. In the illustrated embodiment, a plurality of pins 114 positioned about the external edge of frame component 102 are used for this purpose. Pins 114 penetrate the substrate 20 at corresponding locations to hold it in place. In some forms, substrate 20 can be positioned on component 102 and held under tension, for example biaxial tension, using pins 114 or any other suitable mechanism to secure the substrate 20 to the frame component 102. In certain aspects, the substrate 20 is in a wetted condition (for example with high purity water) when applied and / or as secured to the frame component 102, As well, in certain aspects, the substrate 20 is a multilaminate substrate including a plurality of layers laminated to one another (see e.g, discussions below), and the layers can be individually applied and secured in sequence to the frame component 102, Again, those layers can be in a wetted condition when applied and / or as secured to the frame component 102, Thereafter, the frame component 100 can be assembled to the frame component 102 / substrate 20 combination for example as discussed above. The creation of a continuous, compressed peripheral band of the substrate surrounding the side surface of the substrate 20 to be coated, as discussed above, can eliminate stress concentration regions in the substrate 20 that might otherwise occur during drying operations for the coating and substrate 20 (e.g. stress concentration regions aligned with discretely located pins 114). It has been found that such stress concentration regions can lead to the formation of undesirable wrinkles in the substrate 20 and / or the formed coating 40C as discussed below. Optionally also, the insert plate 104 can be positioned against the first side surface 22 or second side surface 24 of the substrate 20. While in some embodiments such an assembly can be directly used in a coating operation(s) as described herein, in preferred forms the assembly is subjected to conditions to dry the porous sheet substrate 20 (in wetted condition) prior to the coating operation(s). Any suitable drying technique can be used, including as examples air drying, oven drying, convection drying, lyophilization and / or vacuum pressing, Drying conducted at temperatures not exceeding about 50°C, for example at a temperature in the range of about 20X to about 50cC, will be preferred in some aspects. Drying conditions that result in a decreased thickness and a decreased porosity of the of the porous sheet substrate 20, and in particular of the inner region of the porous sheet substrate 20 that occurs within openings 106 and 108, are preferred. Such drying condition can include drying while compressing the porous sheet substrate, for example as may be achieved by vacuum pressing the frame / substrate 20 assembly, thereby resulting in a vacuum pressed porous sheet substrate 20. In such cases, it is also preferred to have insert plate 104 received in one of openings 106 and 108 and against the corresponding first side surface 22 or second side surface 24 of the porous sheet substrate 20, thereby drying the substrate 20 against a surface of the insert plate 104. As shown in the illustrated embodiment, such surface of the insert plate 104 can be a generally planar surface and can thereby facilitate the formation of a dried, flat inner region of porous sheet substrate 20 occurring within openings 106 and 108 to be coated.
[0046] Turning now to a discussion of FIGs. 1-2 along with FIGs. 3-8, shown in the latter FIGs. are stages of one embodiment of a method of coating, and a coated medical product obtained thereby. FIG. 3 in particular provides a cross-sectional view of the assembly of FIG. 2 positioned with the first side surface 22 of substrate 20 positioned facing upwardly and generally horizontally with respect to gravity. This provides a pooling volume bounded by first side surface 22 and the inner wall surfaces 110 of frame component 100, As shown in FIG, 4, a volume of a first liquid coating medium 40L containing one or more polymeric substances has been applied to the first side surface 22 of the substrate 20. The first liquid coating medium 40L can be applied in any suitable manner. In beneficial embodiments, the first coating medium 401 will be applied in a controlled volume from a volume-measuring device. The volume measuring device can be any suitable such a device, including, for example, a syringe, a pipette, or the like. Additionally, in beneficial embodiments, the volume of the first liquid coating medium 401 will be applied by gravitational flow onto the first side surface 22. The applied volume of the first liquid coating medium 401 can then be caused to level on the first side surface 22 of the substrate 20 thereby forming a first liquid coating medium surface 40L-S. Preferably, the applied volume of the first liquid coating medium 401 is allowed to level to gravity without contacting the liquid coating medium with any mechanical element that applies a force to spread the liquid coating medium on the first side surface 22 and / or to drive the liquid coating medium into the porous structure of the porous sheet substrate 20. The use of such a mechanical element, if used, could remove amounts of the applied volume of the first liquid coating medium 40L that adhere to the mechanical element, thus diminishing the ability to control the volume of the first liquid coating medium 401 that is dried and / or otherwise treated to form a coating (see discussions below) and thus the level of loading of the polymeric substance(s) in the coating, in some aspects, the spreading of the applied volume of the first liquid coating medium 401 upon the first side surface 22 may be facilitated by methods that apply forces to the liquid coating medium 401 that are other than gravity in a direction normal (perpendicular) to the first side surface 22, but that avoid contact of the liquid coating medium 401 with a mechanical element configured for spreading the liquid coating medium. Such processes may for example include vibration, tilting the substrate 20 (e.g. by tilting the frame / substrate assembly as described herein) relative to horizontal to gravity, application of forced air or other gas, and / or other such methods. The spread liquid coating medium 401 can in some aspects then be allowed to self-level to gravity with the first side surface 22 positioned horizontal to gravity. In other aspects, such non-mechanical-contact spreading methods are not used, and the applied volume of the liquid coating medium 401 is allowed to spread and level to gravity with the substrate 20 remaining static in position with the first side surface 22 horizontal to gravity and without the use of any mechanical element that contacts the liquid coating medium 401 to spread it after it has been applied to the first side surface 22. As shown for example in FIG. 4, the leveled volume of the first coating medium can in some forms pool on the first side surface 22 of the substrate 20, contact the peripherally-bounding inner wall surfaces 110 of the frame component 100, and form a leveled liquid coating medium surface 401-S directly interfacing an overlying gaseous atmosphere.
[0047] The viscosity of the first liquid coating medium 401 can be controlled to facilitate its spreading and / or leveling, and in particular aspects its self-leveling to gravity. The viscosity can be controlled by any suitable means, including as examples the molecular weight of the polymer substance(s) contained in the first liquid coating medium 401, the concentration of the polymeric substance(s) contained in the first liquid coating medium 401, the temperature of the first liquid coating medium 401, and / or other factors. Where self-leveling to gravity of the first liquid coating medium 401 is utilized, it is preferred to control its viscosity so that self-leveling occurs within about five minutes, more desirably within about three minutes, and even more desirably within about two minutes. The self-leveled first liquid coating medium 401 can have a first portion that has penetrated into pores of the porous sheet substrate 20, but preferably not completely through the thickness of the porous sheet substrate 20, and a second portion residing above the first side surface 22 of the porous sheet substrate 20.
[0048] Referring now particularly to FIG. 4 in conjunction with FIG. 5, after application and leveling of the first liquid coating medium 401 on the first side surface 22, the frame / substrate assembly can be subjected to conditions to treat the first liquid coating medium 401 to form a first coating 40C, for example including drying conditions to remove solvent from the first liquid coating medium 401 and form a first coating 40C including the polymeric substance(s) that were in the first liquid coating medium 401. Other treating conditions may also be used in forming the first coating 40C, for example including crosslinking polymeric substance(s) of the coating medium 401 (potentially combined with drying) or cooling and thereby solidifying molten polymeric substance(s) of the coating medium 40L. In certain aspects herein, any suitable drying conditions may be employed. These may include, for example, air drying, oven drying, vacuum drying, convection drying, or another drying technique, or combinations thereof, it has been found that convection drying is particularly useful to provide a suitable rate of drying to benefit the qualities of the formed first coating on the substrate 20. Convection drying or other drying techniques are desirably conducted at relatively moderate temperatures, for example, temperatures not exceeding about 50° C. Preferred are convection drying or other drying methods during which the liquid surface 401-S of the first liquid coating medium 40L is freely exposed to and forms a liquid-gas interface with a gaseous drying atmosphere. This is contrasted to a drying method during which the liquid surface 40L-S is impinged and covered by a solid material, for example a gas-permeable solid film pressed against the first liquid coating medium 40L and interposed between the first liquid coating medium 401 and a gaseous drying atmosphere. As well, preferred are convection drying or other drying methods that are conducted at atmospheric pressure and / or above atmospheric pressure.
[0049] In advantageous forms, the dried first coating 40C penetrates only partially through the thickness of the porous sheet substrate 20. For these purposes, the applied first liquid coating medium 401 can be dried and / or otherwise treated to form first coating 40C without having penetrated through the entire thickness of the porous sheet substrate 20. The level of penetration of the coating medium 401 can be controlled, for example, by the viscosity of the medium 401, the porosity of the substrate 20, the forces or lack of ferees imparted on the applied medium 401 (e.g. a lack of use of any mechanical spreading element, such as a blade or a roller, that also imparts a driving force to the medium 40Lthat causes it to penetrate Into the thickness of the substrate 20), and the time period between application of the medium 40L to the first side surface 22 and drying of the medium 40L to a non-flowable state. Any one or a combination of these and / or other factors can be controlled to form a first coating 40C that penetrates only partially through the thickness of the porous sheet substrate. Also in advantageous forms, the dried first coating 40C includes a conforms! layer of the polymeric substance(s) occurring overtop the first side surface 22 of the substrate 20. The conformal layer of the polymeric substance(s) can be characterized as molecules of the polymeric substance(s) self-coalesced onto the first side surface 22 under the force of gravity. Such a self-coalesced polymeric substance(s) layer can be prepared using drying methods as discussed above in which the liquid surface 40L-S of the first liquid coating medium 40L is freely exposed to and forms a liquid-gas interface with a gaseous drying atmosphere. In this manner, the coating surface 40C-S of the dried coating 40C takes a form resultant of self-coalescing of molecules of the polymeric substance(s) under the force of gravity as the solvent of the first liquid coating medium 40L is evaporated or otherwise removed. This is contrasted to a coating surface form defined by a surface of a film or other solid material impinging upon the medium 40L during drying. Additionally, it has been found that peripherally securing the region of the porous sheet substrate 20 within the opening 106 against shrinkage in the plane of the substrate 20 with the frame components 100 and 102 during drying of the liquid coating medium 40L can be beneficially used to facilitate obtaining a flat product with a wrinkle-free coating surface 40C-S.
[0050] As illustrated in FIGs. 4 and 5, during the application, leveling, and / or drying of the first liquid coating medium 40L to form coating 40C, the insert plate 104 can be positioned underneath and against the second side surface 24 of the substrate 20. It has been found that the presence of the insert plate 104 during these coating steps facilitates maintaining a flat condition of the substrate 20 and obtaining a flat product having the substrate 20 and the first coating 40C thereon.
[0051] In some embodiments herein, a coated medical product can include the substrate 20 and the coating 40C, and can be free from any coating on the second side surface 24 of the substrate 20, For such products, the substrate 20 with coating 40C thereon as depicted in FIG. 5, or a segment thereof, can be isolated and further processed herein (e.g. packaged and / or sterilized as described below) to provide a coated medical product. In one form, a segment of the coated substrate 20 as depicted in FIG. 5 is cut away, for example by die cutting, from a remainder of the coated substrate 20. The segment can for example substantially correspond to the inner segment of the coated substrate occurring within the aligned openings 106 and 108 of the frame components 100 and 102. Such products can in some forms thus have coating 40C coinciding with the entire first side surface 22 of the substrate 20, with all peripheral edges of the products presenting an edge of the coating 40C and an edge of the substrate 20.
[0052] In other embodiments herein, a coating will also be applied to the second side surface 24 of substrate 20 to provide a coated medical product. Such a coating can be compositionally the same as the coating 40C or can be compositionally different from the coating 40C. With reference to FIGs. 6-8, one embodiment of a method for preparing such coated medical products will be described. Generally, such a method can include repeating the above-described steps for applying coating 40C to first side surface 22 in respect of the second side surface 24, with the same liquid coating medium or a different liquid coating medium.
[0053] In this regard, shown in FIG. 6 is a view of the frame / substrate assembly of FIG. 5 in an inverted position and having insert plate 104 removed. Thus, second side surface 24 of substrate 20 is positioned upward and generally horizontal relative to gravity. This provides a pooling volume bounded by second side surface 24 and the inner wall surfaces 112 of frame component 102, As shown in FIG. 6, a volume of a second liquid coating medium 42L containing one or more polymeric substances, which can be compositionally the same as or different from the first liquid coating medium 40L, has been applied to the second side surface 24 of the substrate 20. The second liquid coating medium 421 can be applied in any suitable manner. In beneficial embodiments, the second liquid coating medium 42L will be applied in a controlled volume from a volume-measuring device. The volume-measuring device can be any suitable such a device, including, for example, a syringe, a pipette, or the like. Additionally, in beneficial embodiments, the volume of the second liquid coating medium 421 will be applied by gravitational flow onto the second side surface 24. The applied volume of the second liquid coating medium 42L can then be caused to level on the second side surface 24 of the substrate 20 thereby forming a second liquid coating medium surface 42L-S. Preferably, the applied volume of the second liquid coating medium 42L is allowed to level to gravity without contacting the liquid coating medium with any mechanical element that applies a force to spread the liquid coating medium on the second side surface 24 and / or to drive the liquid coating medium into the porous structure of the porous sheet substrate 20. The use of such a mechanical element, if used, could remove amounts of the applied volume of the second liquid coating medium 42L that adhere to the mechanical element, thus diminishing the ability to control the volume of the second liquid coating medium 42L that is dried and / or otherwise treated to form a coating (see discussions below) and thus the level of loading of the applied polymeric substance(s) in the coating. In some aspects, the spreading of the applied volume of the second liquid coating medium 42L upon the second side surface 24 may be facilitated by methods that apply forces to the liquid coating medium 421 that are other than gravity in a direction normal (perpendicular) to the second side surface 24, but that avoid contact of the liquid coating medium 42L with a mechanical element configured for spreading the liquid coating medium. Such processes may for example include vibration, tilting the substrate 20 (e.g. by tilting the frame / substrate assembly as described herein) relative to horizontal to gravity, application of forced air or other gas, and / or other such methods. The spread liquid coating medium 421 can in some aspects then be allowed to self-level to gravity with the second side surface 24 positioned horizontal to gravity. In other aspects, such non-mechanical-contact spreading methods are not used, and the applied volume of the liquid coating medium 421 is allowed to spread and level to gravity with the substrate 20 remaining static in position with the second side surface 24 horizontal to gravity and without the use of any mechanical element that contacts the liquid coating medium 421 to spread it after it has been applied to the second side surface 24. As shown for example in FIG. 6, the leveled volume of the second liquid coating medium 421 can in some forms pool on the second side surface 24 of the substrate 20, contact the peripherally-bounding inner wall surfaces 112 of the frame component 102, and form a leveled liquid coating medium surface 42L-S directly interfacing an overlying gaseous atmosphere. The viscosity of the second liquid coating medium 421 can be controlled to facilitate its spreading and / or leveling, and in particular aspects its self-leveling to gravity. The viscosity can be controlled by any suitable means, including as examples the molecular weight of the polymer substance(s) contained in the second liquid coating medium 42L, the concentration of the polymeric substance(s) contained in the second liquid coating medium 421, the temperature of the second liquid coating medium 421, and / or other factors. Where self-leveling to gravity of the second liquid coating medium 421 is utilized, it is preferred to control its viscosity so that self-leveling occurs within about five minutes, more desirably within about three minutes, and even more desirably within about two minutes. The self-leveled second liquid coating medium 421 can have a first portion that has penetrated into pores of the porous sheet substrate 20, but preferably not completely through the thickness of the porous sheet substrate 20, and a second portion residing above the second side surface 24 of the porous sheet substrate 20.
[0054] Referring now particularly to FIG. 7 in conjunction with FIG. 6, after application and leveling of the second liquid coating medium 421 on the second side surface 24, the frame / substrate assembly can be subjected to drying and / or other treating conditions to form a second coating 42C including the polymeric substance(s) that were in the second liquid coating medium 42L. Other treating conditions that may be used in forming the second coating 42C include for example crosslinking polymeric substance(s) of the coating medium 421 (potentially combined with dryingj or cooling and thereby solidifying molten polymeric substance(s) of the coating medium 421. In certain aspects herein, any suitable drying conditions may be employed. These may include, for example, air drying, oven drying, vacuum drying, convection drying, or another drying technique, or combinations thereof. It has been found that convection drying is particularly useful to provide a suitable rate of drying to benefit the qualities of the formed second coating on the substrate 20. Convection drying or other drying techniques are desirably conducted at relatively moderate temperatures, for example, temperatures not exceeding about 50” C. Preferred are convection drying or other drying methods during which the liquid surface 42L-S of the second liquid coating medium 421 is freely exposed to and forms a liquid-gas interface with a gaseous drying atmosphere. This is contrasted to a drying method during which the liquid surface 42L-S is impinged and covered by a solid material, for example a gas-permeable solid film pressed against the second liquid coating medium 421 and interposed between the second liquid coating medium 42L and a gaseous drying atmosphere. As well, preferred are convection drying or other drying methods that are conducted at atmospheric pressure and / or above atmospheric pressure.
[0055] In advantageous forms, the second coating 42C penetrates only partially through the thickness of the porous sheet substrate 20. For these purposes, the applied second liquid coating medium 421 can be dried and / or otherwise treated to form second coating 42C without having penetrated through the entire thickness of the porous sheet substrate 20. The level of penetration of the coating medium 42L can be controlled, for example, by the viscosity of the medium 421, the porosity of the substrate 20, the presence of polymeric substance(s) of the first coating 40C in pores within the thickness of substrate 20, the forces or lack of forces imparted on the applied medium 42L (e.g. a lack of use of any mechanical spreading element, such as a blade or a roller, that also imparts a driving force to the medium 421 that causes it to penetrate into the thickness of the substrate 20), the time period between application of the medium 42L to the second side surface 24 and drying and / or other treatment of the medium 421 to obtain a non-flowable state. Any one or a combination of these and / or other factors can be controlled to form a second coating 42C that penetrates only partially through the thickness of the porous sheet substrate.
[0056] Also in advantageous forms, the second coating 42C includes a conformal layer of its polymeric substance(s) occurring overtop the second side surface 24 of the substrate 20. The conformal layer of such polymeric substance(s) can be characterized as molecules of the polymeric substance(s) seif-coalesced onto the second side surface 24 under the force of gravity. Such a self-coalesced polymeric substance(s) layer can be prepared using drying methods as discussed above in which the liquid surface 42L-S of the second liquid coating medium 42L is freely exposed to and forms a iiquid-gas interface with a gaseous drying atmosphere, in this manner, the coating surface 42C-S of the dried second coating 42C takes a form resuitant of seif-coalescing of moiecuies of its polymeric substance(s) under the force of gravity as the solvent of the second liquid coating medium 42L is evaporated or otherwise removed. This is contrasted to a coating surface form defined by a surface of a film or other solid materia! impinging upon the second liquid coating medium 42L during drying. Additionally, as discussed above in connection with formation of the first coating 40C, it has been found that peripherally securing the region of the substrate 20 within the opening 108 against shrinkage in the plane of the substrate 20 with the frame components 100 and 102 during drying and / or other treatment of the liquid coating medium 421 can be beneficially used to facilitate obtaining a fiat product with a wrinkle-free coating surface 42C-S.
[0057] As illustrated in FIGs, 6 and 7, in some method embodiments, during the appiication, leveling, and / or treatment of the second liquid coating medium 421 to form the second coating 42C, the insert piate 104 can be absent (e.g. where there is no support positioned underneath and against the first coating 40C on the substrate 20), It has been found that flat coated medical products including substrate 20 and coatings 40C and 42C can be prepared. Also, in this way, contact of the first coating 40C with any solid surface during steps for forming second coating 42C can be avoided. It wiil be understood, however, that in other embodiments the insert plate 104 or another similar or different support may be positioned beneath and against the first coating 40C during step(s) for forming the second coating 42C.
[0058] In some embodiments herein, the substrate 2G with coatings 40C and 42C thereon as depicted in FIG. 7, or a segment thereof, can be isolated and further processed herein (e.g. packaged and / or sterilized as described below) to provide a coated medical product. In one form, a segment of the coated substrate 20 as depicted in FIG. 7 is cut away, for example by die cutting, from a remainder of the coated substrate 20. The segment can for example substantially correspond to the inner segment of the coated substrate occurring within the aligned openings 106 and 108 of the frame components 100 and 102. FIG. 8 depicts one such coated medical product 50 including the substrate 20, coating 40C presenting surface 40C-S, and coating 42C presenting surface 42C-S. Such products can in some forms thus have coating 40C coinciding with the entire first side surface 22 of the substrate 20 and coating 42C coinciding with the entire second side surface 24 of substrate 20, with all peripheral edges of the product 50 presenting an edge 40E of the coating 40C, an edge 20E of the substrate 20, and an edge 42E of the coating 42C.
[0059] It will be understood that coated medical products having coating 40C but not coating 42C, as discussed above, can have the same features shown in FIG. 8, except lacking coating 42C (and thus also lacking its surface 42C-S and edge 42Ej. Such coated medical products can instead have second side surface 24 of substrate 20 exposed as an outermost surface of the coated medical product.
[0060] It has been found that during coating-forming operations as discussed herein, unless properly constrained, a flat coated medical product may deform from its flat condition and / or develop wrinkles in the substrate or coating(s). This may especially be the case where the substrate relaxes (loses stiffness) and / or swells in the presence of the applied liquid coating medium(s) which wet the substrate, and then develops stress and / or shrinks as it is thereafter dried and / or otherwise treated to form a coating. Differential shrinking between the applied coating(s) and the substrate during drying / treating operation(s) may also contribute to the deformation and / or wrinkles. These aspects can occur when using substrates that include one or more decellularized ECM layers, for example including multilaminate ECM substrates as discussed herein, which exhibit relaxation and swelling in the presence of many liquid coating mediums, including for example aqueous liquid coating mediums as disclosed herein. Applied coating(s) including hydrogel-forming polymeric substance(s) and the extent to which they shrink on drying / treating as compared to the substrate on which they are coated (e.g. a substrate including one or more ECM layers, such as a multilaminate ECM substrate as disclosed herein) are also believed to contribute to the deformation and / or wrinkles in the product. Accordingly, as noted above, during the drying / treating operation(s), the coated medical product is preferably held to its desired shape, such as a flat shape, for example by a circumferential frame as discussed herein.
[0061] It has also been found that after the drying and / or other treating operation(s) to form a coating, unless constrained, a flat or other shaped coated medical product may deform from its fiat or other shaped condition as it equilibrates to the moisture level (humidity) of its surrounding atmospheric environment, for example a manufacturing environment. Accordingly, in some embodiments, after the drying and / or other treating operation, the coated medical product is held to its desired shape, such as a flat shape or a non-flat shape e.g. as discussed herein, for a time period for moisture equilibration to its surrounding atmospheric environment. Such time period may for exampie be for five minutes to ten hours. For these purposes, coated medical products manufactured using frames as discussed may be retained in their frames after the drying operation and during the moisture equilibration period, after which they may be isolated from their frames (e.g. cut or otherwise removed) as discussed above and will retain their desired (e.g. flat) shape.
[0062] As disclosed above, the first coating 40C and when included the second coating 42C, in preferred forms, each only partially penetrate through the thickness of the porous sheet substrate 20. Where coatings 40C and 42C are both included, their respective penetration depths through the thickness of the substrate 20 can be such that the coatings 40C and 42C to not overlap in the thickness of the substrate 20. In such forms, the coated medical product 50 can include an interior region of the substrate 20, for example a thickness stratum, in which the pores of the substrate 20 are not filled with any polymeric substance(s), but rather can be open pores, e.g. providing an open porous stratum within the thickness of the substrate 20. Such open pores or open porous stratum can facilitate cellular invasion into the substrate 20 upon implantation of the coated medical product 50. Where an open porous stratum is present in product 50, it can in some embodiments represent at least about 10% of the thickness of the substrate 20, for example with this value being in the range of about 10% to about 80% of the thickness of the substrate 20. In other forms where coatings 40C and 42C are both included, their respective penetration depths partially through the thickness of the substrate 20 can be such that the coatings overlap in the thickness of the substrate 20. In such forms, the coated medical product 50 can include an interior region of the substrate 20, for example a thickness stratum, in which the pores of the substrate 20 contain and are potentially filled with a polymeric substance mixture including the polymeric substance(s) of both coatings 40C and 42C. Such a polymeric substance mixture can be present within a stratum of the thickness of the substrate. This can provide a stratified coated medical product 50 including an intermediate thickness stratum of the substrate 20 having the polymeric substance mixture flanked on a first side by a first thickness stratum including the polymeric substance(s) of the first coating 40C but free of the polymeric substance(s) of the second coating 42C, and flanked on a second side by a second thickness stratum including the polymeric substance(s) of the second coating 42C but free of the polymeric substance(s) of the first coating 40C. Where the first coating 40C and the second coating 42C include differing polymeric substance(s) from one another, the intermediate., first and second thickness strata can differ from one another in respect of the types of polymeric substance(s) that are present. Where the first coating 40C and the second coating 42C include the same polymeric substance(s), the intermediate, first and second thickness strata can differ from one another in respect of the ratio of multiple polymeric substance(s) to one another, in respect of the abundance of the polymeric substance(s) present (e.g. expressed in terms of dry weight parts of the polymeric substance(s) per unit surface area of the substrate 20 and / or in terms of the dry weight parts of the polymeric substance(s) per dry weight parts of the substrate 20), in some forms. Where an intermediate thickness stratum is present in product 50 including a polymeric substance mixture including the polymeric substance(s) of both coatings 40C and 42C, it can in some embodiments represent at least about 10% of the thickness of the substrate 20, for example with this value being in the range of about 10% to about 80% of the thickness of the substrate 20. In certain beneficial forms, the polymeric substance(s) of coating 40C and / or 42C can be more abundant in regions external of the first and second side surfaces 22 and 24 (externalized portions of the coating 40C and / or 42C) than within the substrate 20 (internalized portions of the coating 40C and / or 42C). For example, in some variants, at least about 60% by dry weight, or at least about 70% by dry weight, of the total load of the polymeric substance(s) of the coating 40C and / or the coating 42C will be present in the externalized portion of the coating that occurs atop the first side surface 22 and / or the second side surface 24, respectively. A distribution of the polymeric substance(s) toward the regions external of and / or adjacent the first and second side surfaces 22 and 24 can be particularly advantageous where the first and second coatings 40C and 42C have a purpose of modulating the interaction of surfaces of the coated medical product SO with surrounding patient tissue upon implantation, for example, where the first and second coatings 40C and 42C are lubricious coatings, anti-tissue-adhesion coatings, or adhesive coatings. Such lubricious, anti-tissue-adhesion, or adhesive coatings can in some forms be provided by the inclusion of hydrogel-forming polymeric substance(s) in or as the first and second coatings 40C and 42C.
[0063] While in the embodiments illustrated in FIGs. 1-8 the frame components 100 and 102 define a pooling volume on each side of the substrate 20, in other embodiments one or more frame components can be used that define a pooling volume on only one side of the substrate 20. For example, a frame component similar to frame component 102 except lacking the opening 108 (e.g, being a solid sheet across its width and breadth) could be used in combination frame component 100 to provide a pooling volume within opening 106 on only one side of substrate 20. Such frame components could be used in the preparation of a substrate 20 coated only on one side, e.g. with the first coating 40C on side 22, or could be reversed with respect to the substrate 20 after preparation of the first coating to apply a second coating, e.g, coating 42C on side 24. In addition, while in the embodiments illustrated in FIGs. 1-8 the frame components 100 and 102 each define only a single pooling volume, it will be understood that in other embodiments frame component 100 and / or frame component 102 can define multiple discrete openings to provide multiple pooling volumes. Such multiple-opening frame component(s) can be used to prepare substrates 20 coated (e.g. with coating 40C and / or coating 42C} in multiple discreet regions corresponding to the multiple openings of the frame component(s). Such coated substrates 20 could be further processed to provide coated medical products with coating patterns thereon having discrete coated regions or could be cut at or within the edges of the coated regions to isolate the multiple coated regions as multiple separate coated medical products having coating(s) coinciding with their entire first side and / or their entire second side. These and other variations will be apparent to persons skilled in the field from the descriptions herein.
[0064] As noted above, coated products of the present disclosure include a porous sheet substrate. Generally speaking, a wide variety of porous sheet substrates are known and can be used. Preferably, the porous sheet substrate is a collagenous (i.e. coliagen- containing) sheet substrate and / or is conformable to patient tissue when wet.
[0065] Particular advantage will be provided by sheet substrates that incorporate a remodelable materia!. Such remodelable materials can be provided by a collagen- containing materials, e.g., provided in a reconstituted or non-reconstituted form, for example where the collagen has been obtained from a warm-blooded vertebrate, and especially a mammal, including as examples a porcine, bovine, ovine, or caprine mammal. Isolated collagen-containing materials can be processed so as to have remodelable, angiogenic properties and promote cellular invasion and ingrowth, and in this regard, inventive constructs comprising a remodelable material can be effective upon implantation to stimulate ingrowth of adjacent tissues into the construct such that the remodelable material gradually breaks down and becomes replaced by new patient tissue so that a new, remodeled tissue structure is generated.
[0066] Suitable remodelable materials that can be included in or that can constitute the porous sheet substrate can be decellularized membranous tissue segments, which can be provided by collagenous extracellular matrix (ECM) materials. For example, suitable collagenous materials include ECM materials such as those comprising submucosa, renal capsule membrane, amnion, dermal collagen, dura mater, pericardium, fascia lata, serosa, peritoneum or basement membrane layers, including liver basement membrane. Suitable submucosa materials for these purposes include, for instance, intestinal submucosa including small intestinal submucosa, stomach submucosa, urinary bladder submucosa, and uterine submucosa. Collagenous sheet substrates comprising submucosa (potentially along with other associated tissues) useful in aspects of the present disclosure can be obtained by harvesting such tissue sources and delaminating the submucosa-containing matrix from smooth muscle layers, mucosal layers, and / or other layers occurring in the tissue source. Collagenous sheet substrates that are pliable when wet so as to be easily conformable to patient tissue will be beneficially useful in certain aspects herein. For additional information as to some materials useful in the present invention, and their isolation and treatment, reference can be made, for example, to U.S. Patent Nos. 4,902,508, 5,554,389, 5,993,844, 6,206,931, 6,099,567, and 8,187,619.
[0067] Remodelable ECM tissue materials harvested as intact sheets from a mammalian source and processed to remove cellular debris advantageously retain at least a portion of and potentially ali of the native collagen microarchitecture of the source extracellular matrix. This matrix of collagen fibers provides a scaffold to facilitate and support tissue ingrowth, particularly in bioactive ECM implant materials, such as porcine small intestinal submucosa or SIS (Surgisis® Biodesign™, Cook Medical, Bloomington IN), that are processed to retain an effective level of growth factors and other bioactive constituents from the source tissue. In this regard, when an inventive construct incorporates this sort of material, cells will invade the remodelable material upon implantation eventually leading to the generation of a newly-remodeled patient tissue structure.
[0068] Continuing with a discussion of materials that can be utilized in embodiments of the present disclosure, when used, a submucosa-containing or other ECM tissue used in the invention is preferably highly purified, for example, as described in U.S, Patent No, 6,206,931 to Cook et al. or in U.S. Patent No. 8,192,763 of Cook Biotech Incorporated. Thus, preferred ECM material will exhibit an endotoxin level of less than about 12 endotoxin units (Ell) per gram, more preferably less than about 5 EU per gram, and most preferably less than about 1 EU per gram. As additional preferences, the submucosa or other ECM material may have a bioburden of less than about 1 colony forming units (CFU) per gram, more preferably less than about 0.5 CPU per gram. Fungus levels are desirably similarly low, for example less than about 1 CFU per gram, more preferably less than about 0.5 CFU per gram. Nucleic acid levels are preferably less than about 5 pg / mg, more preferably less than about 2 pg / mg, and virus levels are preferably less than about 50 plaque forming units (PFU) per gram, more preferably less than about 5 PFU per gram. These and additional properties of submucosa or other ECM tissue taught in U.S. Patent No. 6,206,931 and / or in U.S. Patent No. 8,192,763 may be characteristic of any ECM tissue used in the present invention.
[0069] A typical layer thickness for an as-isolated submucosa or other ECM tissue layer that can be used in embodiments herein ranges from about 50 to about 250 microns when fully hydrated, more typicaliy from about 50 to about 200 microns when fully hydrated, although isolated layers having other thicknesses may also be obtained and used. These layer thicknesses may vary with the type and age of the animal used as the tissue source. As well, these layer thicknesses may vary with the source of the tissue obtained from the animal source. As disclosed herein, in certain embodiments, porous sheet substrates will include or be provided by a laminate of multiple layers of submucosacontaining ECM material and / or other ECM material.
[0070] A decellularized submucosa or other remodelable ECM tissue material for use herein as or in the porous sheet substrate may retain one or more growth factors native to a source tissue for the tissue material, such as but not limited to basic fibroblast growth factor (FGF-2), transforming growth factor beta (TGF-beta), epidermal growth factor (EGF), cartilage derived growth factor (CDGF), and / or platelet derived growth factor (PDGF). As well, submucosa or other ECM materials when used in the invention may retain other bioactive agents native to the source tissue such as but not limited to proteins, glycoproteins, proteoglycans, and glycosaminoglycans. For example, ECM materials may include retained heparin, heparin sulfate, hyaluronic acid, fibronectin, and / or cytokines, native to a source tissue. Submucosa-containing or other ECM materials, when used as or in a porous sheet substrate herein, can be derived from any suitable organ or other tissue source, usually sources containing connective tissues. The ECM materials processed for use in the invention will typically include abundant collagen, most commonly being constituted at least about 80% by weight collagen on a dry weight basis. Such naturally-derived ECM materials will for the most part include collagen fibers that are non-randomly oriented, for instance occurring as generally uniaxial or multi-axial but regularly oriented fibers. When processed to retain native bioactive factors, the ECM material can retain these factors interspersed as solids between, upon and / or within the collagen fibers. Particularly desirable naturally-derived ECM materials for use in the invention will include significant amounts of such interspersed, non-collagenous solids that are readily ascertainable under light microscopic examination with appropriate staining. Such non- collagenous solids can constitute a significant percentage of the dry weight of the ECM material in certain inventive embodiments, for example at least about 1%, at least about 3%, and at least about 5% by weight in various embodiments of the invention.
[0071] A submucosa-containing or other ECM material that can be used in embodiments of the present disclosure may also exhibit an angiogenic character and thus be effective to induce angiogenesis in a host engrafted with the material. In this regard, angiogenesis is the process through which the body makes new blood vessels to generate increased blood supply to tissues. Thus, angiogenic materials, when contacted with host tissues, promote or encourage the formation of new blood vessels into the materials. Methods for measuring in vivo angiogenesis in response to biomaterial implantation have recently been developed. For example, one such method uses a subcutaneous implant model to determine the angiogenic character of a material. See, C. Heeschen et al., Nature Medicine 7 (2001), No. 7, 833-839. When combined with a fluorescence microangiography technique, this model can provide both quantitative and qualitative measures of angiogenesis into biomaterials. C. Johnson et al., Circulation Research 94 (2004), No. 2, 262-268. Further, in addition or as an alternative to the inclusion of retained bioactive components native to a source tissue, nan-native bioactive substances such as those synthetically produced by recombinant technology or other methods (e.g., genetic materia! such as DMA), may be incorporated into an ECM material. These non-native bioactive substances may be naturally-derived or recombinantly produced proteins that correspond to those natively occurring in an ECM tissue, but perhaps of a different species. These non-natlve bioactive substances may also be drug substances.
[0072] Illustrative drug substances that may be added to materials include, for example, anticlotting agents, e.g. heparin, antibiotics, statins, anti-inflammatory agents, thrombuspromoting substances such as blood clotting factors, e.g., thrombin, fibrinogen, and the like, and anti-proliferative agents, e.g. taxol derivatives such as paclitaxel. Such nonnative bioactive components can be incorporated into and / or onto ECM material in any suitable manner, for example, by surface treatment (e.g., spraying) and / or impregnation (e.g., soaking), just to name a few.
[0073] Porous sheet substrates herein can incorporate or in some forms be constituted of xenograft material (i,e., cross-species material, such as tissue material from a nonhuman donor to a human recipient), allograft material (i.e., interspecies material, with tissue material from a donor of the same species as the recipient), and / or autograft material (i.e., where the donor and the recipient are the same individual). Further, any exogenous bioactive substances incorporated into an ECM material may be from the same species of animal from which the ECM material was derived (e.g. autologous or allogenic relative to the ECM material) or may be from a different species from the ECM material source (xenogenic relative to the ECM material). In certain embodiments, ECM material of the substrate will be xenogenic relative to the patient receiving the graft, and any added exogenous material(s) will be from the same species (e.g. autologous or allogenic) as the patient receiving the graft. Illustratively, human patients may be treated with xenogenic ECM materials (e.g. porcine-, bovine- or ovine-derived) that have been modified with exogenous human material(s) as described herein, those exogenous materials being naturally derived and / or recombinantly produced. When used in aspects of the present disclosure, ECM materials or decellularized membranous tissue segments may be essentially free of additional, non-native crosslinking, or may contain additional crosslinking. Such additional crosslinking may be achieved by photo-crosslinking techniques, by chemical crosslinkers, or by protein crosslinking induced by dehydration or other means. However, because certain crosslinking techniques, certain crosslinking agents, and / or certain degrees of crosslinking can destroy the remodeiable properties of a remodelable material, where preservation of remodelable properties is desired, any crosslinking of the remodelable ECM material can be performed to an extent or In a fashion that allows the material to retain at least a portion of its remodelable properties. Chemical crosslinkers that may be used include for example aldehydes such as glutaraldehydes, diimides such as carbodiimides, e.g., l-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, ribose or other sugars, acyl-azide, sulfo-N-bydroxysuccinamide, or polyepoxide compounds, including for example poiyglycidyl ethers such as ethyleneglycol diglycidyl ether, available under the trade name DENACOL EX810 from Nagese Chemical Co., Osaka, Japan, and glycerol polyglycerol ether available under the trade name DENACOL EX 313 also from Nagese Chemical Co. Typically, when used, polyglycerol ethers or other polyepoxide compounds will have from 2 to about 10 epoxide groups per molecule.
[0074] Remodelable ECM materials having a relatively more open matrix structure (i.e., higher porosity) are capable of exhibiting different material properties than those having a relatively more closed or collapsed matrix structure. For example, an ECM material having a relatively more open matrix structure is generally softer and more readily compliant to an implant site than one having a relatively more closed matrix structure. Also, the rate and amount of tissue growth in and / or around a remodelable material can be influenced by a number of factors, including the amount of open space available in the material's matrix structure for the invasion and support of a patients tissue-forming components, such as fibroblasts. Therefore, a more open matrix structure can provide for quicker, and potentially more, growth of patient tissue in and / or around the remodelable materia!, which in turn, can lead to quicker remodeling of the material by patient tissue.
[0075] In certain embodiments, the porosity of a layer or layers of ECM material of the sheet substrate to be coated as described herein is reduced by drying the material(s) under compression, in general, compressing a pliable open matrix material, such as a pliable ECM material, increases the material's density and reduces the material's porosity by collapsing pores of the open matrix. As is the case in certain aspects of the present disclosure, when such a material is dried while being compressed, the open matrix structure can become somewhat fixed in this relatively higher density, lower porosity state (i.e., in a relatively more collapsed pore state). The density of these or other materials of the sheet substrate can be conventionally determined. For example, the volume and the weight occupied by an amount of the material(s) can be determined, and the volume divided by the weight to provide a density expressed as a unit volume / unit weight (e.g. in grams / cubic centimeter) of the material. In addition, the porosity of a materlal(s) of the sheet substrate can be conventionally determined. For example, mercury intrusion porosimetry can be used to determine the porosity of the material(s), e.g. as described by Janis et al., J. Biomater. Appi., May 2012, Vol. 26 No. 8, 1013-1033.
[0076] Sheet substrates used in certain embodiments of the present disclosure can include a plurality of ECM material layers bonded together, a plurality of non-ECM material layers bonded together, or a combination of one or more ECM material layers and one or more non-ECM material layers bonded together, illustratively, two or more ECM segments can be fused or bonded together using a bonding technique, such as chemical cross-linking or vacuum pressing during dehydrating conditions. An adhesive, glue or other bonding agent may also be used in achieving a bond between material layers to form the laminated segment(s) of the pouch products disclosed herein. A combination of bonding technique(s) and bonding agent(s) may also be used to bond ECM material sheets or layers, or other sheets of material, to one another in a laminate structure. Sheet substrates used in certain embodiments of the present disclosure can include a plurality of ECM materia! layers bonded together, a plurality of non-ECM materia! layers bonded together, or a combination of one or more ECM material Sayers and one or more non-ECM material Sayers bonded together.
[0077] Deceiiularized collagenous ECM materia! layers, for example used in laminate porous sheet substrates herein, will in some forms include a compact collagen sublayer formed by relatively densely packed collagen fibers adjacent to a loose collagen sublayer formed by less densely packed collagen fibers, with the compact collagen sublayer being less porous than the loose collagen sublayer. For example, deceiiularized collagenous ECM material layers that include submucosal tissue can include as such a compact sublayer a collagenous lamina propria sublayer or a collagenous stratum compactum sublayer, attached to an adjacent collagenous sublayer having less densely packed fibers than those of the lamina propria sublayer or collagenous stratum compactum sublayer. When multiple (e.g. two to ten) such deceiiularized collagenous ECM material layers are laminated together in a multilaminate porous sheet substrate herein, the presence of the included compact sublayers can provide less porous strata distributed through the thickness of the substrate. This can impact the extent of penetration of a first liquid coating medium and / or second liquid coating medium as discussed herein into the porous sheet substrate and thus the resulting compositional structure of the coated medical product.
[0078] A variety of dehydration-induced bonding methods can be used to fuse ECM or other material layers together in forming a multilaminate porous sheet substrate. In one preferred embodiment, multiple layers or other pieces of ECM material and / or other sheet material as described herein are compressed under dehydrating conditions. The term "dehydrating conditions" can include any mechanical or environmental condition which promotes or induces the removal of water from the material. To promote dehydration of the compressed material, at least one of the two surfaces received directly against and compressing the sheet material can be water permeable in some embodiments. Dehydration of the material can optionally be further enhanced by applying blotting material, heating the matnx structure or blowing air, or other inert gas, across the exterior of the compressing surfaces. One particularly useful method of dehydration bonding materials, and preferably collagen-containing materials, is lyophilization. In some forms the lyophilization includes first freezing the materials and then subjecting the frozen materials to lyophilization conditions in which frozen liquid within the materials is removed by sublimation.
[0079] Another method of dehydration bonding comprises pulling a vacuum on the layers to be laminated while simultaneously pressing the layers together. In some forms, this can be done by vacuum pressing. During vacuum pressing, dehydration of the layers in forced contact with one another effectively bonds the materials to one another, even in the absence of other agents for achieving a bond, although such agents can be used while also taking advantage at least in part of the dehydration-induced bonding. With sufficient compression and dehydration, the layers can be caused to form a generally unitary multilaminate porous sheet substrate.
[0080] In other forms, the porous sheet substrate may include or be constituted of one or more synthetic polymeric materials. A variety of synthetic polymeric materials including but not limited to bioresorbable and / or non-bioresorbable polymeric materials can be used. Bioresorbable polymers that may be used include, but are not limited to, polyfl- lactic acid), polycaprolactone, poly(lactide-co-glycolide), poly(hydroxybutyrate), poly(hydroxybutyrate-co-vaierate), poiydioxanone, polyorthoester, polyanhydride, polyfglycolic acid), poly(D,L-lactic acid), polyfglycolic acid-co-trimethylene carbonate), polyhydroxyalkanaates, polyphosphoester, polyphosphoester urethane, polyfamino acids), cyanoacrylates, polyftrimethylene carbonate), polyfiminocarbonate), copoiy(ether-esters) (e.g., PEO / PLA), polyalkylene oxalates, polyfester urea) polymers, and polyphosphazenes. These or other bioresorbable materials may be used, for example, where only a temporary function is desired, and / or in combination with non- bioresorbable materials where only a temporary participation by the bioresorable materia! is desired. Non-bioresorbable polymers that may be used include, but are not limited to, polytetrafluoroethylene (PTFE) (including expanded PTFE), polyethylene terephthalate (PET), polyurethanes, silicones, and polyesters and other polymers such as, but not limited to, polyolefins, polyisobutylene and ethylene-alphaolefin copolymers; acrylic polymers and copolymers, vinyl halide polymers and copolymers, such as polyvinyl chloride; polyvinyl ethers, such as polyvinyl methyl ether; polyvinylidene halides, such as polyvinylidene fluoride and polyvinylidene chloride; polyacrylonitrile, polyvinyl ketones; polyvinyl aromatics, such as polystyrene, polyvinyl esters, such as polyvinyl acetate; copolymers of vinyl monomers with each other and olefins, such as ethylene methyl methacrylate copolymers, acrylonitriie styrene copolymers, ABS resins, and ethylene-vinyl acetate copolymers; polyamides, such as Nylon 66 and polycaprolactam; alkyd resins, polycarbonates; polyoxymethylenes; polyimides; polyethers; epoxy resins, polyurethanes; rayon; and rayon-triacetate.
[0081] Preferred embodiments of the present disclosure are coated medical products that include a multilaminate porous sheet substrate, especially a multilaminate porous sheet substrate including a plurality of deceliularlzed ECM layers, for example any of those discussed herein, laminated together. The lamination of the layers together can be achieved by any suitable technique described herein but is preferably achieved by vacuum pressing or another technique that Involves compression of the layers against one another under dehydrating conditions, which can beneficially reduce the porosity of the starting layers used in the lamination. With particular reference now to FIGS. 9-13, described will be an illustrative embodiment of a coated medical product including a multilaminate porous sheet substrate and its preparation. Generally, the steps, materials (e.g. first and second liquid coating media and their respective polymeric substance(s)) and equipment (e.g. frame components and insert) in the preparation of such a coated medical product can correspond to those disclosed above in respect of FIGs. 1-8, with additional features in certain respects as described below.
[0082] FIG. 9 provides a cross-sectional view illustrating an embodiment of a multilaminate porous sheet substrate 60 including a plurality of deceliularlzed ECM layers (four layers In the specific depicted embodiment) 60a, 60b, 60c and 60d laminated together. Porous sheet substrate 60 has a first side surface 62 and a second side surface 64 opposite the first surface. FIG. 10 depicts a volume of a first liquid coating medium 66L applied to the multi laminate porous sheet substrate 60 and including a first portion 66L-a pooled above the surface 62 and a second portion 66L-b infiltrating pores of the substrate 60 and extending only partially through the thickness of the substrate 60 {in the illustrated embodiment being confined to within the outermost ECM layer 60a providing the first side surface 62), The volume of the first liquid coating medium 66L forms a liquid surface 66L-S, for example self-leveled to gravity as discussed hereinabove.
[0083] Referring now particularly to FIG. 11 in conjunction with FIG. 10, after application and leveling of the first liquid coating medium 66L on the first side surface 62, treating conditions can be used to form a first coating 66C including the polymeric substance(s) that were in the first liquid coating medium 66L, for example drying conditions can be applied to remove solvent from the first liquid coating medium SSL and form a first coating 66C including the polymeric substance(s) that were in the first liquid coating medium 66L, In advantageous forms as illustrated, the first coating 66C includes a conformal layer 66C-a of the polymeric substance(s) occurring overtop the first side surface 62 of the multilaminate porous sheet substrate 60. The conformal layer 66C~a of the polymeric substance(s) can in some forms be characterized as molecules of the polymeric substance(s) self-coalesced onto the first side surface 62 under the force of gravity. Such a self-coalesced polymeric substance(s) layer 66C-a can be prepared using drying methods as discussed above in which the liquid surface 66L-S of the first liquid coating medium 66L is freely exposed to and forms a liquid-gas interface with a gaseous drying atmosphere. In this manner, the coating surface 66C-S of the dried coating 66C takes a form resultant of self-coalescing of molecules of the polymeric substance(s) under the force of gravity as the solvent of the first liquid coating medium 66L is evaporated or otherwise removed. The first coating 66C also includes an infiltrating portion 66C-b including molecules of the polymeric substance(s) from the first liquid coating medium 66L infiltrating pores of the substrate 60 and extending only partially through the thickness of the substrate 60 (in the illustrated embodiment being confined to within the outermost ECM layer 60a providing the first side surface 62). In some embodiments herein, a coated medical product can include the substrate 60 and the coating 66C, and can be free from any coating on the second side surface 64 of the substrate 60. For such products, the substrate 60 with coating 66C thereon as depicted in FIG. 11, or a segment thereof, can be isolated and further processed herein (e.g. packaged and / or sterilized as described below) to provide a coated medical product. In one form, a segment of the coated substrate 60 as depicted in FIG. 11 is cut away, for example by die cutting, from a remainder of the coated substrate 60. The segment can for example substantially correspond to the inner segment of the coated substrate occurring within the aligned openings 106 and 108 of the frame components 100 and 102 ( see FIGs. 1-3) . Such products can in some forms thus have coating 66C coinciding with the entire first side surface 62 of the substrate 60, with ail peripheral edges of the products presenting an edge of the coating 66C and an edge of the substrate 60.
[0084] In other embodiments herein, a coating will also be applied to the second side surface 64 of substrate 60 to provide a coated medical product. Such a coating can be compositionally the same as the coating 66C or can be compositionally different from the coating 66C. With reference to FIGs. 12-13, one embodiment of a method for preparing such coated medical products will be described. Generally, such a method can include repeating the above-described steps for applying coating 66C to first side surface 62 in respect of the second side surface 64, with the same liquid coating medium or a different liquid coating medium.
[0085] In this regard, shown in FIG. 12 is a view of the substrate 60 and coating 66C of FIG. 10 in an inverted position. Thus, second side surface 64 of substrate 60 is positioned upward and generally horizontal reiative to gravity. As shown in FIG. 12, a volume of a second liquid coating medium 681 containing one or more polymeric substances, which can be compositionally the same as or different from the first liquid coating medium 661, has been applied to the second side surface 64 of the substrate 60. The applied volume of the second liquid coating medium 681 includes a first portion 681-a pooled above the surface 64 and a second portion 681-b infiltrating pores of the substrate 60 and extending only partially through the thickness of the substrate 60 (in the illustrated embodiment being confined to within the outermost ECM layer 60d providing the second side surface 64). The volume of the second liquid coating medium 681 forms a liquid surface 68L-S, for example self-leveled to gravity as discussed herein.
[0086] Referring now to FIG. 13 in conjunction with FIG. 12, after application and leveling of the second liquid coating medium 681 on the second side surface 64, treating conditions can be used to form a second coating 68C including the polymeric substance(s) that were in the second liquid coating medium 68L, for example drying conditions can be applied to remove solvent from the second liquid coating medium 68L and form a second coating 68C including the polymeric substance(s) that were in the second liquid coating medium 68L. in advantageous forms as illustrated, the second coating 68C includes a conformal layer 68C-a of the polymeric substance(s) occurring overtop the second side surface 64 of the multilaminate porous sheet substrate 60. The conformal layer 68C-a of the polymeric substance(s) can in some forms be characterized as molecules of the polymeric substance(s) self-coalesced onto the second side surface 64 under the force of gravity. Such a seif-coalesced polymeric substance(s) layer 68C-a can be prepared using drying methods as discussed above in which the liquid surface 68L-S of the second liquid coating medium 68L is freely exposed to and forms a liquid-gas interface with a gaseous drying atmosphere. In this manner, the coating surface 68C-S of the dried coating 68C takes a form resultant of self -coalescing of molecules of the polymeric substance(s) under the force of gravity as the solvent of the second liquid coating medium 68L is evaporated or otherwise removed. The second coating 68C also includes an infiltrating portion 68C-b including molecules of the polymeric substance(s) from the second liquid coating medium 681 infiltrating pores of the substrate 60 and extending only partially through the thickness of the substrate 60 (in the illustrated embodiment being confined to within the outermost ECM layer 60d providing the second side surface 64).
[0087] In some embodiments herein, the substrate 60 with coatings 66C and 68C thereon as depicted in FIG. 13, or a segment thereof, can be isolated and further processed herein (e.g. packaged and / or sterilized as described below) to provide a coated medical product. In one form, a segment of the coated substrate 60 as depicted in FIG. 13 is cut away, for example by die cutting, from a remainder of the coated substrate 60. The segment can for example substantially correspond to the inner segment of the coated substrate occurring within the aligned openings 106 and 108 of the frame components 100 and 102 (see FIGs. 1-7). Such coated medical products can include the substrate 60, coating 66C presenting surface 66C-S, and coating 68C presenting surface 68C-S. in some forms such coated medical products can have coating 66C coinciding with the entire first side surface 62 of the substrate 60 and coating 68C coinciding with the entire second side surface 64 of substrate 60, with all peripheral edges of the product presenting an edge of the coating 66C, an edge of the substrate 60, and an edge of the coating 68C.
[0088] It will be understood that coated medical products having coating 66C but not coating 68C, as discussed above, can have coating 66C coinciding with the entire first side surface 62 of the substrate 60, with all peripheral edges of the product presenting an edge of the coating 66C and an edge of the substrate 60, and with second side surface 64 of substrate 60 exposed as an outermost surface of the coated medical product.
[0089] As disclosed above, the first coating 66C and when included the second coating 68C, in preferred forms, each only partially penetrate through the thickness of the multilaminate porous sheet substrate 60. Where coatings 66C and 68C are both Included, their respective penetration depths through the thickness of the substrate 60 can be such that the coatings 66C and 68C to not overlap in the thickness of the substrate 60. In such forms, the coated medical product can include an interior region of the substrate 60, for example a thickness stratum, in which the pores of the substrate 60 are not filled with any polymeric substance(s), but rather can be open pores, e.g. providing an open porous stratum within the thickness of the substrate 60. Such open pores or open porous stratum can facilitate cellular Invasion into the substrate 60 upon implantation of the coated medical product. Where an open porous stratum is present in the product intermediate to coatings 66C and 68C, it can in some embodiments represent at least about 10% of the thickness of the substrate 60, for example with this value being in the range of about 10% to about 80% of the thickness of the substrate 60. Additionally or alternatively, such an open porous stratum can include the entirety of at least one ECM layer of a multilaminate porous sheet substrate including at least three, for example three to ten, ECM layers laminated together (in the depicted embodiment including two such layers 60b and 60c) and / or the infiltrating portions 66C-b and 68C-b of coatings 66C and 68C, respectively, can be limited to occurring within respective outermost ECM layers (e.g. 60a and 60d) of the multilaminate porous sheet substrate (e.g. 60) that provide first and second outer surfaces (e.g. 62 and 64) of the multilaminate porous sheet substrate.
[0090] As in the embodiments discussed in conjunction with FIGs. 1-8 above, the first liquid coating medium 66L and / or the second liquid coating medium 681 can be applied to the substrate 60 in any suitable manner. In beneficial embodiments, the first liquid coating medium 66L and / or the second liquid coating medium 68L will be applied in a controlled volume from a volume-measuring device. The volume-measuring device can be any suitable such a device, including, for example, a syringe, a pipette, or the like. Additionally, in beneficial embodiments, the volume of the liquid coating medium 661 and / or 681 will be applied by gravitational flow onto the respective side surface 62 or 64. The applied volume of the liquid coating medium 661 and / or 681 can then be caused to level on the respective first or second side surface 62 or 64 of the substrate 60 thereby forming a respective first and / or second liquid coating medium surface 661- S / 68L-S. Preferably, the applied volume of the first and / or second liquid coating medium 66L / 68L Is allowed to level to gravity without contacting the liquid coating medium with any mechanical element that applies a force to spread the liquid coating medium on the respective first or second side surface 62 / 64 and / or to drive the liquid coating medium into the porous structure of the multilaminate porous sheet substrate 60. The use of such a mechanical element, if used, could remove amounts of the applied volume of the first and / or second liquid coating medium 66L / 68L that adhere to the mechanical element, thus diminishing the ability to control the volume of the liquid coating medium 66L / 68L that is dried and / or otherwise treated to form a coating and thus the level of loading of the applied polymeric substance(s) in the coating(s). in some aspects, the spreading of the applied volume of the first and / or second liquid coating medium 66L / 68L upon the respective first or second side surface 62 / 64 may be facilitated by methods that apply forces to the liquid coating medium 661 / 681 that are other than gravity in a direction normal to the respective first or second side surface 62 / 64, but that avoid contact of the liquid coating medium 66L / 68L with a mechanical element configured for spreading the liquid coating medium. Such processes may for example include vibration, tilting the substrate 60 (e.g. by tilting a frame / substrate assembly as described herein) relative to horizontal to gravity, application of forced air or other gas, and / or other such methods. The spread liquid coating medium 66L / 68L can in some aspects then be allowed to self-level to gravity with the respective first or second side surface 62 / 64 positioned horizontal to gravity, in other aspects, such non- mechanical-contact spreading methods are not used, and the applied volume of the liquid coating medium 66L / 68L is allowed to spread and level to gravity with the substrate 60 remaining static in position with the respective first or second side surface 62 / 64 horizontal to gravity and without the use of any mechanical element that contacts the liquid coating medium 66L / 68L to spread it after it has been applied to the respective first or second side surface 62 / 64. These or other non-mechanical contact methods for spreading the liquid coating medium 66L / 68Lcan facilitate maintaining the applied volume of liquid coating medium 66L / 68L on the substrate 60 and thus greater precision in controlling the loading of the polymeric substance(s) in the coating(s) 66C and 68C.
[0091] As disclosed above, in other forms where a coating is applied to each side surface of the porous sheet substrate, the respective penetration depths of the coatings partially through the thickness of the substrate can be such that the coatings overlap in the thickness of the substrate. Reference will now be made to FIGs. 14-17, which illustrate certain embodiments of such products that incorporate a multilaminate porous sheet substrate including a plurality of ECM layers laminated together. FIG. 14 provides a cross-sectional view illustrating an embodiment of a multilaminate porous sheet substrate 80 including a plurality of deceilularized ECM layers (four layers in the specific depicted embodiment) 80a, 80b, 80c and 80d laminated together. Porous sheet substrate 80 has a first side surface 82 and a second side surface 84 opposite the first surface. FIG. 14 also depicts a volume of a first liquid coating medium 861 applied to the multilaminate porous sheet substrate 80 and including a first portion 86L-a pooled above the surface 82 and a second portion 86L-b infiltrating pores of the substrate 80 and extending only partially through the thickness of the substrate 80 (in the illustrated embodiment being confined within the substrate 80 such that it does not penetrate into the opposite outermost ECM layer 80d providing the second side surface 84). The volume of the first liquid coating medium 861 forms a liquid surface 86L-S, for example self-leveled to gravity as discussed hereinabove.
[0092] Referring now particularly to FIG. IS in conjunction with FIG. 14, after application and leveling of the first liquid coating medium 86L on the first side surface 82, drying and / or other treating conditions can be applied to form a first coating 86C including the polymeric substance(s) that were in the first liquid coating medium 861. In advantageous forms as illustrated, the first coating 86C includes a conformal layer 86C-a of the polymeric substance(s) occurring overtop the first side surface 82 of the multilaminate porous sheet substrate 80. The conformal layer 86C-a of the polymeric substance(s) can in some forms be characterized as molecules of the polymeric substance(s) self-coalesced onto the first side surface 82 under the force of gravity. Such a self-coalesced polymeric substance(s) layer 86C-a can be prepared using drying methods as discussed above in which the liquid surface 86L-S of the first liquid coating medium 861 is freely exposed to and forms a liquid-gas interface with a gaseous drying atmosphere. In this manner, the coating surface 86C-S of the coating 86C takes a form resultant of self-coalescing of molecules of the polymeric substance(s) under the force of gravity as the solvent of the first liquid coating medium 861 is evaporated or otherwise removed. The first coating 86C also includes an infiltrating portion 86C-b including molecules of the polymeric substance(s) from the first liquid coating medium 861 infiltrating pores of the substrate 80 and extending only partially through the thickness of the substrate 80 (in the illustrated embodiment being confined within the substrate 80 outermost ECM layer 60a providing the first side surface 62).
[0093] In the embodiments herein where first and second coatings overiap in the thickness of the substrate, a coating will also be applied to the second side surface 84 of substrate 80 to provide the coated medical product. Such a coating can be compositionally the same as the coating 86C or can be compositionally different from the coating 86C. Generally, the second coating can be applied by repeating the above-described steps for applying coating 86C to first side surface 82 in respect of the second side surface 84, with the same liquid coating medium or a different liquid coating medium.
[0094] In this regard, shown in FIG. 16 is a view of the substrate 80 and coating 86C of FIG. 15 in an inverted position. Thus, second side surface 84 of substrate 80 is positioned upward and generally horizontal relative to gravity. As shown in FIG. 16, a volume of a second liquid coating medium 88L containing one or more polymeric substances, which can be compositionally the same as or different from the first liquid coating medium 861, has been applied to the second side surface 84 of the substrate 80. The applied volume of the second liquid coating medium 88L includes a first portion 88L-a pooled above the surface 84 and a second portion 88L-b infiltrating pores of the substrate 80 and extending only partially through the thickness of the substrate 80 {in the illustrated embodiment being confined within substrate 80 such that it does not penetrate into the outermost ECM layer 80a providing the first side surface 82 of the substrate 80). The volume of the second liquid coating medium 881 forms a liquid surface 88L-S, for example self-leveled to gravity as discussed herein. As shown in FIG. 16, the thus- prepared product includes an intermediate thickness stratum 90M intermediate to a first thickness stratum 90-86C and a second thickness stratum 90-881. The intermediate thickness stratum 90M includes a mixture of polymeric substance(s) molecules from the second liquid coating medium 881 and the previously-applied first coating 86C. The intermediate thickness stratum 90M may also include solvent from the second liquid coating medium 88L, and it will be understood that in some cases this solvent may redissolve some or all of the polymeric substance(s) molecules of the previously-applied first coating 86C. The first thickness stratum 90-86C will include polymeric substance(s) molecules of the first coating 86C but not of the second liquid coating medium 881. The second thickness stratum 90-881 will include polymeric substance(s) molecules of the second liquid coating medium 88L but not of the first coating 86C.
[0095] Referring now to FIG. 17 in conjunction with FIG. 16, after application and leveling of the second liquid coating medium 881 on the second side surface 84, drying and / or other treating conditions can be applied to form a second coating 88C including the polymeric substance(s) that were in the second liquid coating medium 881. In advantageous forms as illustrated, the second coating 88C includes a conformal layer 88C-a of the polymeric substance(s) occurring overtop the second side surface 84 of the multilaminate porous sheet substrate 80. The conformal layer 88C-a of the polymeric substance(s) can in some forms be characterized as molecules of the polymeric substance(s) self-coalesced onto the second side surface 84 under the force of gravity. Such a self-coalesced polymeric substance(s) layer 88C-a can be prepared using drying methods as discussed above in which the liquid surface 881- S of the second liquid coating medium 88L is freely exposed to and forms a liquid-gas interface with a gaseous drying atmosphere. In this manner, the coating surface 88C-S of the coating 88C takes a form resultant of self-coalescing of molecules of the polymeric substance(s) under the force of gravity as the solvent of the second liquid coating medium 88L is evaporated or otherwise removed. The second coating 88C also includes an infiltrating portion 88C-b including molecules of the polymeric substance(s) from the second liquid coating medium 881 infiltrating pores of the substrate 80 and extending only partially through the thickness of the substrate 80 (in the illustrated embodiment being confined within substrate 80 such that it does not penetrate into the opposite outermost ECM layer 80a providing the first side surface 82 of the substrate 80). As shown in FIG. 17, the thus- prepared product includes an intermediate thickness stratum 90MC intermediate to first thickness stratum 90-86C and second thickness stratum 90-88C. The intermediate thickness stratum 90MC includes a mixed coating including polymeric substance(s) of both the second coating 88C and the first coating 86C. The first thickness stratum 90- 86C includes polymeric substance(s) of the first coating 86C but not of the second coating 88C. The second thickness stratum 90-88C includes polymeric substance(s) of the second coating 88C but not of the first coating 86C.
[0096] Where the first coating 86C and the second coating 88C include differing polymeric substance(s) from one another, the intermediate, first and second thickness strata 90MC, 90*86C and 90-88C can differ from one another in respect of the types of polymeric substance(s) that are present. Where the first coating 86C and the second coating 88C include the same polymeric substance(s), the intermediate, first and second thickness strata 90MC, 90-86C and 90-88C can differ from one another in respect of the ratio of multiple polymeric substance(s) to one another and / or in respect of the abundance of the polymeric substance(s) present (e.g. expressed in terms of dry weight parts of the polymeric substance(s) per unit surface area of the substrate 80 and / or in terms of the dry weight parts of the polymeric substance(s) per dry weight parts of the substrate 80), in some forms. Intermediate thickness stratum 90MC can in some embodiments represent at least about 10% of the thickness of the substrate 80, for example with this value being in the range of about 10% to about 80% of the thickness of the substrate 80. In addition or alternatively, the first stratum 90-86C can include at least the entire thickness of an outermost ECM layer of substrate 80 providing side surface 82 and / or the second stratum 90-88C can include at least the entire thickness of an outermost ECM layer of the substrate 80 providing second side surface 84. While in the specific illustrate embodiment the muitilaminate substrate 80 has four ECM layers, it will be understood that these features can also be present for example in multilaminate substrates having other numbers of ECM layers laminated together, for example at least three and in some forms three to ten ECM layers laminated together.
[0097] In certain aspects herein, the substrate 80 with coatings 86C and 88C thereon as depicted in FIG, 17, or a segment thereof, can be isoiated and further processed herein (e.g. packaged and / or sterilized as described below) to provide a coated medical product. In one form, a segment of the coated substrate 80 as depicted in FIG. 17 is cut away, for example by die cutting, from a remainder of the coated substrate 80. The segment can for example substantially correspond to the inner segment of the coated substrate occurring within the aligned openings 106 and 108 of the frame components 100 and 102 (see FIGs. 1-7). Such coated medical products can include the substrate 80, coating 86C presenting surface 86C-S, and coating 88C presenting surface 88C-S. in some forms such coated medical products can have coating 86C coinciding with the entire first side surface 82 of the substrate 80 and coating 88C coinciding with the entire second side surface 84 of substrate 80, with all peripheral edges of the product presenting an edge of the intermediate thickness stratum 90MC, an edge of the first thickness stratum 90-86C, and an edge of the second thickness stratum 90-88C.
[0098] While coated medical products shaped as a flat sheet are desirable for many applications, for other applications the coated medical product may benefit from having a shape other than a flat sheet. Additional embodiments of the present disclosure relate to such coated medical products having a shape other than a flat sheet, to methods for their preparation, and to methods for their use. Such coated medical products may have a curved sheet shape, for example having an elongate curl shape in which the coated substrate forms walls curving circumferentially to less than or equal to 360 degrees so as to present longitudinally-extending edges in a non-overiapped condition, or having an elongate curl shape in which the coated substrate forms walls curving circumferentially to greater than 360 degrees so as to present longitudinally- extending edges in an overlapped condition, in some forms, these or other coated medical products having a shape other than a flat sheet can be prepared by re-shaping a starting coated medical product that is in a flat sheet form, for example a flat coated medical product as described herein and / or prepared using a method as described herein. For these purposes, a dried starting coated medical product that is in a flat sheet form can be moistened with a liquid, for example an aqueous liquid such as water, and dried while holding the product in a shape other than a flat sheet form, to impart memory for a shape other than a flat sheet form, for example a shape as described above. The starting coated medical product can be moistened before and / or after positioning it to the shape other than a flat sheet. As well, in beneficial forms, the moistening can be achieved by subjecting the coated medical product to a gaseous atmosphere including a vapor of the moistening liquid, for example a gaseous atmosphere humidified with water. In still further advantageous forms, the moistening of the coated medical product will be controlled to increase conformability of and remove shape memory of the product for the flat sheet form but avoid causing the coating(s) on the substrate to become flowable, for example under the force of gravity. This can be beneficial in preserving qualities of the coating(s) in the transition from the shape of a fiat sheet to a shape other than a fiat sheet.
[0099] With reference now to FIGs. 18*19, illustrative embodiments of coated medical products having a shape other than a flat sheet, and methods by which they can be prepared, will be described, in particular, FIG. 18 provides a cross-sectional view of a coated medical product 120 mounted and held in a curled shape having walls curving circumferentially to less than 360 degrees. Coated medical product 120 has a porous sheet substrate as described herein, preferably a multilaminate porous sheet substrate including or constituted of a plurality of decelluiarized ECM layers laminated together. Coated medical product 120 also includes at least a first coating including polymeric substance(s), e.g. as described herein, in some forms only a first coating including polymeric substance(s), e.g, as described herein, and in some forms both a first coating including polymeric substance(s) and a second coating including polymeric substance(s), e.g. as described herein. In the illustrative embodiment of FIG. 18, the coated medical product 120 is held in the curled shape mounted on an inner support 122, such as a tube. Inner support 122 has a convexly-curved (e.g. cylindrical) outer surface 124 against which is received a concavely-curved inner surface 126 of the product 120, An outer member 128 holds the product 120 in place with its surface 126 against the outer surface 124 of support 122. In particular, outer member 128 includes a concavely- curved (e.g. cylindrical) inner surface 130 received against a convexly-curved outer surface 132 of the product 120. In some forms, outer member 128 and / or inner support 122 can be permeable to a gas including a moistening vapor as discussed below that is used to moisten the product 120. For these purposes outer member 128 and / or inner support 122 can as examples be porous or perforated. In certain aspects outer member 128 and / or inner support 122 can be composed of a porous film of spunbound polymer (e.g. polyethylene) fibers, for example as occurs in Tyvek® films, that is permeable to the gas including the moistening vapor.
[0100] The product layup shown in FIG. 18 can be subjected to any suitable conditions to moisten the product 120. In preferred forms, the product layup is exposed to a gas environment, for example within an environmentally-controlled chamber, that includes a vapor that condenses upon and moistens the product 120. A humidified (i.e, with water) gas, such as humidified air, can be used. Humidified air or other gas having a relative humidity level of at least 90%, or at least 95%, can be used, for example such humidity level being in the range of 90-100% or in the range of 95-100% in some aspects. The humidified air or other gas, or other moistening gas environment, can be at any suitable temperature, with temperatures in the range of about 4°C to about GO'X, or about 15°C to about 40°C, being used in some embodiments. The period of time for exposure of the product layup to the moistening gas environment will typically be at least about 3 minutes, or at least about 10 minutes, and in some aspects in the range of about 3 minutes to about 24 hours or about 20 minutes to about 5 hours. As disclosed above, these and other conditions of the moistening operation will desirably be controlled to increase conformability of and remove shape memory of the product 120 for a flat sheet form but avoid rendering flowable the coating(s) on the substrate of the product 120.
[0101] After the moistening operation, e.g. as discussed above, the product layup of FIG. 18 can be subjected to drying conditions. Any suitable drying conditions can be used, including as examples air drying, oven drying, convection drying, lyophilization and / or vacuum pressing. Drying conducted at temperatures not exceeding about 50cC, for example at a temperature in the range of about 20°C to about 50 'C, wili be preferred in some aspects. The dried product 120 will have shape memory for a shape other than a flat shape, for example for a curled shape having walls curving circumferentially to less than 360 degrees. Such curled shape may be as product 120 was shaped around inner support 122 or a curled shape after product has partially but not completely rebounded toward a flat shape. The support 122, product 120 layup, moistening and drying conditions can be controlled so that the relaxed shape of the completed product 120, absent applied external forces, is the desired shape.
[0102] Referring to F!G. 19, shown is a perspective view of an embodiment of an elongate curled product 120 that can be prepared as described above. As illustrated, product 120 has walls that curve circumferentially less than 360 degrees, for example walls that curve to circumferentially extend greater than 270 degrees but no more than about 355 degrees, so as to leave a first longitudinally-extending edge 134 and a second longitudinally-extending edge 136 that are not circumferentially overlapped with respect to one another, defining a gap 138 therebetween. Product 120 has a concavely- curved inner surface 126 and an opposite convexly-curved outer surface 132.
[0103] As discussed above, product 120 includes a porous sheet substrate, for example any of those disclosed herein, and at least a first coating including polymeric substance(s), for example any of those disclosed herein. Beneficial coated medical products 120 can be formed from coated medical products as described hereinabove In conjunction with FIGs. 8-17. In this regard, where the product 120 includes only a first coating including polymeric substance(s) and the first coating penetrates only partially through the porous sheet substrate, in some forms the concavely-curved inner surface 126 of the product 120 is provided by the surface of the first coating (e.g. coating surface 40C-S or 66C-S as described above), and in other forms the convexly-curved outer surface 132 of the product 120 is provided by the surface of the first coating (e.g. coating surface 40C-S or 66C-S as described above).
[0104] On the other hand, where the product 120 includes both a first coating including polymeric substance(s) and a second coating including polymeric substance(s), each of which penetrates only partially through the porous sheet substrate, in some forms the concavely-curved inner surface 126 of the product 120 is provided by the surface of the first coating (e.g. coating surface 40C-S or 66C-S as described above) while the convexly- curved outer surface 132 of the product 120 is provided by the surface of the second coating (e.g. coating surface 42C-S or 68C-S as described above), and in other forms the concavely-curved inner surface 126 of the product 120 is provided by the surface of the second coating (e.g, coating surface 42C-S or 68C-S as described above) while the convexly-curved outer surface 132 of the product 120 is provided by the surface of the first coating (e.g. coating surface 40C-S or 66C-S as described above).
[0105] With reference now to FIGs. 20-21, additional illustrative embodiments of coated medical products having a shape other than a flat sheet, and methods by which they can be prepared, will be described. In particular, FIG. 20 provides a cross-sectional view of a coated medical product 140 mounted and held in a curled shape having walls curving circumferentially to greater than 360 degrees. Coated medical product 140 has a porous sheet substrate as described herein, preferably a multilaminate porous sheet substrate including or constituted of a plurality of decellularized ECM layers laminated together. Coated medical product 140 also includes at least a first coating including polymeric substance(s), e.g. as described herein, in some forms only a first coating including polymeric substance(s), e.g. as described herein, and in some forms both a first coating including polymeric substance(s) and a second coating including polymeric substance(s), e.g. as described herein. In the illustrative embodiment of FIG. 20, the coated medical product 140 is held in the curled shape mounted on an inner support 142, such as a tube. Inner support 142 has a convexly -curved (e.g. cylindrical) outer surface 144 against which is received a concavely-curved inner surface 146 of the product 140. An outer member 148 holds the product 140 in place with its surface 146 against the outer surface 144 of support 142. In particular, outer member 148 includes a concavely- curved inner surface 150 received against a convexly-curved outer surface 1S2 of the product 140. The product 140 is held in a curled shape having curved walls that circumferentially extend greater than 360 degrees, providing an overlap region 154 in which the product 140 overlaps itself. In some forms the overlap region 154 is moderate in extent, for example wherein the curved walls of product 140 circumferentially extend greater than 360 degrees but no more than about 450 degrees, or no more than about 400 degrees. As shown, in the overlap region 154 of the product layup, a layer of the outer member 148 is interposed between the adjacent surfaces of the product 140. This can prevent any potential bonding of the product 140 to itself in the overlap region 154 upon moistening and then drying, in some forms, outer member 148 and / or inner support 142 can be permeable to a gas Including a moistening vapor as discussed below that is used to moisten the product 140. For these purposes outer member 148 and / or inner support 142 can as examples be porous or perforated. In certain aspects outer member 148 and / or inner support 142 can be composed of a porous film of spunbound polymer (e.g. polyethylene) fibers, for example as occurs in Tyvek® films, that is permeable to the gas including the moistening vapor.
[0106] The product layup shown in FIG. 20 can be subjected to any suitable conditions to moisten the product 140, for example any of those conditions disclosed above with respect to the product layup shown in FIG. 18. As disclosed above, these and other conditions of the moistening operation will desirably be controlled to increase conformability of and remove shape memory of the product 140 for a flat sheet form but avoid rendering flowable the coating(s) on the substrate of the product 140.
[0107] After the moistening operation, e.g. as discussed above, the product layup of FIG. 20 can be subjected to drying conditions. Any suitable drying conditions can be used, including for example any of those disclosed above with respect to the product layup shown in FIG. 18. The dried product 140 will have shape memory for a shape other than a flat shape, for example for a curled shape having walls curving circumferentially to greater than 360 degrees, providing an overlap region 154 in the dried product. Such curled shape, and the overlap region 154, may be as product 140 was shaped around inner support 142 or a curled shape after product has partially but not completely rebounded toward a flat shape, leaving a reduced but nonetheless present overlap region 154. The dried product includes a first longitudinally extending edge 156 and a second longitudinally-extending edge 158 (shown in phantom in FIG. 21), with the overlap region 154 defined between them. The dried product 140 is not bonded to itself in the overlap region 154 and thus can be forced from an original set shape to uncurl the product 140 sufficiently to remove the overlap region 154 and provide a longitudinally- extending opening (e.g. for receiving an elongate tissue structure within the product 140). The force can thereafter be discontinued whereupon the product will re-curl at least toward its original set shape having overlap region 154, potentially to again provide at least some extent an of overlap region, or in some forms whereupon the product will re-curl to its original set shape having overlap region 154. The support 142, product 140 layup, moistening and drying conditions can be controlled so that the relaxed shape of the completed product 140 after drying, absent applied external forces, is a desired shape having a desired overlap region 154.
[0108] As discussed above, product 140 includes a porous sheet substrate, for example any of those disclosed herein, and at least a first coating including polymeric substance(s), for example any of those disclosed herein. Beneficial coated medical products 140 can be formed from coated medical products as described hereinabove in conjunction with FIGs. 8-17. In this regard, where the product 140 includes only a first coating including polymeric substance(s) and the first coating penetrates only partially through the porous sheet substrate, in some forms the concavely-curved inner surface 146 of the product 140 is provided by the surface of the first coating (e.g. coating surface 40C-S or 66C-S as described above), and in other forms the convexly-curved outer surface 152 of the product 140 is provided by the surface of the first coating {e.g. coating surface 40C-S or 66C-S as described above).
[0109] On the other hand, where the product 140 includes both a first coating including polymeric substance(s) and a second coating including polymeric substance(s), each of which penetrates only partially through the porous sheet substrate, in some forms the concavely-curved inner surface 146 of the product 140 is provided by the surface of the first coating (e.g. coating surface 40C-S or 66C-S as described above) while the convexly- curved outer surface 152 of the product 140 is provided by the surface of the second coating (e.g. coating surface 42C-S or 68C-S as described above), and in other forms the concavely-curved inner surface 146 of the product 140 is provided by the surface of the second coating (e.g. coating surface 42C-S or 68C-S as described above) while the convexly-curved outer surface 152 of the product 140 is provided by the surface of the first coating (e.g. coating surface 40C-5 or 66C-S as described above). In some embodiments herein, the exposure of the product layup of FIG, 18 or FIG, 20 (or otherwise a product layup constraining the coated medical product to a desired non-flat shape) to a gas environment to moisten the product (e.g. 120 or 140) can occur partially or completely within a controlled environment chamber in which the product (e.g, 120 or 140) is also sterilized, for example by exposure to a humidified gas atmosphere containing ethylene oxide vapor (e.g, at a relative humidity above 90%, or above 95%). Such exposure to moisten the product (e.g. 120 or 140) can occur before, during and / or after a period in which the gas atmosphere within the chamber contains the ethylene oxide vapor. For example, the product (e.g. 120 or 140) can be exposed to a humidified gas atmosphere without ethylene oxide vapor during a period before introduction of ethylene oxide to the chamber and / or during a period after introduction of ethylene oxide to the chamber and clearance of the ethylene oxide from the chamber. For these purposes, during the sterilization and re-shaping, the product layup, for example as depicted in FIG. 18 or FIG. 20, can be enclosed within sterile barrier packaging that is permeable to the humidified gas atmosphere(s) used. Drying of the product (e.g. 120 or 140) after such moistening processes can include any suitable drying method, and in some forms may be or include conditions for degassing the product (e.g. 120 or 140) to remove residual ethylene oxide from the sterilization. In use of the thus-prepared packaged product (e.g. 120 or 140), the product layup (e.g. as depicted in FIG. 18 or FIG. 20) can be removed from the sterile barrier packaging and the re-shaped product (e.g. 120 or 140) separated from the outer member (e.g. 128 or 148) and inner support (e.g. 122 or 142). In some applications, the product (e.g. 120 or 140) can thereafter be implanted in a patient.
[0110] While in some specific discussions above the coated medical product (e.g. 120 or 140) to be reshaped by moistening and then drying is held to a shape for resetting by an inner support and an outer member, it will be understood that other arrangements by which the product is constrained to the shape for resetting may be used, whether they use a single mechanical constraining element or plural mechanical constraining elements, or other means. As disclosed above, coated products herein will include a first coating including polymeric substance(s) and / or a second coating including polymeric substance(s) associated with the porous sheet substrate. A wide variety of polymeric substance{s} will be suitable in the formation of coatings herein. These include as examples naturally-derived polymeric substances and / or synthetic polymeric substances. The polymeric substance(s) can likewise provide a wide variety of functions to the coated medical product. These include for example providing an adhesive coating for example as described in U.S. Patent No. 10,500,309 issued December 10, 2019 or U.S. Patent No. 8,920,443 issued December 30, 2014, or U.S. Patent Application Publication No. US2022023489A1 dated January 27, 2022, a polymer hydrogel layer for example as described in U.S. Patent Application Publication No. US2001031974A1 dated October 18, 2001, an adhesive and / or lubricating polymer hydrogel coating for example as described in U.S. Patent Application Publication No. US2021046221A1 dated February 18, 2021, a drug-eluting coating for example as described in U.S. Patent No. 11,065,368 issued July 20, 2021, an analgesic coating for example as described in U.S. Patent Application Publication No. US2009142400A1 dated June 4, 2009, an anti-tissue-adhesion coating for example as described in U.S. Patent Application Publication No. US2006251702A1 dated November 9, 2006, or other functional coating(s). These and all other references cited herein are hereby incorporated by reference in their entirety, including for their Identification of polymeric substance(s) and porous sheet substrates that may be used in coated medical products herein and for their identification of medical use applications for coated medical products herein.
[0111] Coated medical products of the present disclosure may be configured for and may have any of a wide variety of medical applications. These include for example as bolster materials for reinforcing staple lines, e.g. wherein the coating(s) provide an adhesive function for adhering the porous sheet substrate to a stapler arm, for the repair or reconstruction of patient tissue structures such as body wall structures, e.g. wherein the coating(s) provide anti-tissue-adhesion properties and / or the local delivery of one or more drugs or other bioactive agents, or tendons, ligaments or nerves, e.g. wherein the coating(s) provide lubricating and / or anti-tissue-adhesion properties and / or the local delivery of one or more drugs or other bioactive agents (e.g. heparin, dermatan sulfate, FGF-2 or a neural growth stimulating agent), and others.
[0112] In some forms, the polymeric substance(s) of the first coating and / or second coating will be or include a hydrogel-forming polymeric substance or a combination of hydrogelforming polymeric substances. Examples of the suitable hydrogel-forming polymeric substances may include, but are not limited to, poly-anion polymers (net negative charge to the polymer), including for example polysaccharide polymeric substances such as chondroitin sulfate and / or hyaluronic acid. Additional anionic polymeric substances that may be used include for example chondroitin, alginate, alginic acid, oxidized cellulose (e.g. non -regenerated oxidized cellulose), heparin, and sulfated versions of these polymers, and combinations thereof. In certain forms, the first coating and / or the second coating as disclosed herein will include, as hydrogel -form! ng polymeric substances, a combination of alginic acid or a salt thereof (e.g. sodium alginate) and hyaluronic acid or a salt thereof (e.g. sodium hyaluronate).
[0113] Cationic polymeric substances that may be used in embodiments of the present disclosure include for example poly-lysine, poly-ornithine, polyhexamethylene biguanide (PHMB), polyethyieneimine (PEI), diethylaminoethyl-dextran (DEAE-dextran), poly(amidoamine) (PAMAM), and quaternary ammonium versions of these polymers, and combinations thereof.
[0114] Porous sheet substrates of the present disclosure may be associated with the hydrogel-forming or other polymeric substance in various ways. In some aspects, physical binding of the coating to the porous sheet substrate may be obtained by wetting the substrate with a liquid coating medium containing the polymeric substance(s), preferably in solvated form in the liquid medium, and thereafter drying the liquid coating medium. In the case of using one or more hydrogel-forming polymeric substances, the porous sheet substrate can be wetted with an aqueous liquid coating medium, for example an aqueous sol-gel, including the one or more hydrogel-forming polymeric substances prior to drying, resulting in an interpenetrating network of the polymeric substance(s) entrained in pores of the porous sheet substrate and preferably also a layer or layers of the polymeric substance(s) residing above a surface or surfaces of the substrate.
[0115] In one preparative example, the porous sheet substrate may be wetted with a solution of the hydrogel-forming and / or other polymeric substance(s) prior to drying and sterilization. As dried and / or upon hydration the polymeric substance(s) may be present on the surface of the porous sheet substrate, as well as within internal pores the substrate, and in some forms will not be covalently bound to the porous sheet substrate. This may allow the hydrogel-forming and / or other polymeric substances to be retained at the surface of the porous sheet substrate and may allow migration and diffusion of the polymeric substances(s) within and around the substrate, in such an embodiment no reactive species may be needed between the polymeric substance(s) and the substrate, as the binding interaction may be physical intertangling of chains of the polymeric substance(s). if alginate or another ionic cross-linking polymeric substance is present, this physical intertangling effect can be further increased by introducing cross-link causing ions, for example calcium ions, to ionically cross-link the polymeric substance(s).
[0116] In other forms, covalent linkages may be introduced between the polymeric substance(s) and the substrate. For example, aldehyde reactive groups on the polymeric substance(s) may form covalent linkages by their reaction with primary amine groups on the substrate, for example where the substrate includes a polypeptide containing primary amine groups, such as collagen. As is known, the aldehyde reactive groups may be formed by oxidizing groups on the polymeric substance(s) in the presence of an oxidation agent. The hydrogel-forming or other polymeric substance may be bound to the porous sheet substrate via other known binding techniques. These include, as examples, EDC (l-Ethyl-3-{3-dimethylaminopropyl)~carbodiimide) and N- hydroxysuccinimide (NHS) or N-hydroxysulfoxuccinimide (sulfo-NHS), sulf hydryl / disu Ifide bonding, thio-ene reaction, maleimide, epoxide, imidoester, any "dick" chemistry, or combinations thereof. Porous sheet substrates with aldehyde reactive groups, such as primary amine, tertiary amines, quartenary amines, or substituents with similar chemical properties, may be used in embodiments of the present disclosure. These sheet substrates may be similarly reacted with hydrogel-forming or other polymeric substances to form bonds with the aldehyde groups, or equivalent binding substituents, in the formation of a coated product as described herein.
[0117] In some forms, the polymeric substance(s) can include both a positively charged polymeric substance and a negatively charged polymeric substance. In this case, polyelectrolyte complexation may occur to result in a sol i d / ge I . For example, this may occur at physiological conditions when chitosan and hyaluronic acid are used in mixture as or in the polymeric substance(s) of a coating material herein.
[0118] The polymeric substance(s) utilized may have any suitable molecular weight. ! certain forms, the weight average molecular weight of the polymeric substance(s) will be in the range of about 10,000 Daltons (Da) to 4,000,000 Da, or in the range of about 1,000,00 to 2,000,000 Da.
[0119] In accordance with some embodiments of the present disclosure, coated medical products having a relatively high degree of lubricity may be provided by way of physical interpenetrations of the polymeric substance(s) at least in part into the porous sheet substrate. For example, in some forms, a porous sheet substrate, such as a multilaminate ECM layer substrate as discussed herein, may be coated with in an aqueous liquid coating medium including hyaluronic acid and alginate to at least partially diffuse the liquid coating medium into the membrane, if an ionic geliing polymer is used, care can be taken to avoid calcium or other multivalent cations during coating of the liquid coating medium onto the substrate, as the coating medium may gel prematurely. Once the substrate has been associated with the coating medium to a desired degree, the substrate and coating medium can be dried, for example using any of those coating and drying operations described elsewhere herein. In some embodiments, the alginate may provide some degree of ionic cross-linking in the presence of calcium ions and / or other divalent cations. Examples of divalent cation sources include but are not limited to calcium chloride, calcium acetate, magnesium chloride, and magnesium acetate. In some embodiments, the ionic cross-linking may improve the retention of the hyaluronic acid and alginate over time, and may provide increased lubricity for the treated membrane over time, as compared to embodiments with lower degrees, or no, ionic cross-linking.
[0120] In accordance with some embodiments of the present disclosure, the polymeric substance(s) may include high molecular weight hyaluronic acid (e.g. 1 million Da or more), for example to provide a biocompatible lubricating layer. When used in combination with hyaluronic acid, alginate may also provide some lubricity on its own. Further, alginate may perform as an ionically crosslinking polymer that may facilitate retaining the hyaluronate at the site of implant for a longer period.
[0121] In certain embodiments herein, the dried coating(s) containing polymeric substance(s) on the substrate may provide a reversible adhesive layer that is non-tacky in the dried state but becomes tacky when wetted with water or an otherwise biocompatible aqueous solution such as saline. In this manner, a coated medical device as described herein can be packaged and shipped in a dried state, and then wetted at the point of use (e.g. by attending medical personnel) to render the implantable material tacky. As some examples, suitable polymeric substance(s) for such dried coating(s) include polyvinyl pyrrolidones, polyvinyl alcohols, polyvinyl acetates, vinyl acetate esters, starches, dextrins, dextrans, carboxymethyl cellulose, carboxy methyl ethyl cellulose, hyaluronic acid, alginates, chondroitin sulfates, poly-lactides, gelatin, polyethylene glycols, poloxamers, carbomers, or blends or combinations thereof. Additional polymeric substance(s) that may be used include hydroxypropyl cellulose, pullulan, gellan, carrageenan, xantham gum, and / or guar gum.
[0122] The level of loading of the polymeric substance(s) on the porous sheet substrate may vary with many factors including for example the particular polymeric substance(s) used, the intended function(s) of the applied coating(s), and the intended end use for the coated medical product. In many forms, a coating on the coated medical product will include the polymeric substance(s) at a level of about 0.25 mg / cm2to about 10 mg / cm2of the coating, more typically about 0.5 mg / cm2to about 5 mg / cm2of the coating. It will be understood that such levels may apply to a single coating when the coated medical product includes only a single coating, or may apply separately to multiple (e.g. two) separate coatings when the coated medical product includes multiple separate coatings.
[0123] A liquid coating medium as disclosed herein, for example the first and / or second liquid coating medium as discussed in embodiments above, can include any suitable liquid solvent, including in some forms a mixed solvent. Typically, and especially where the polymeric substance(s) are or include a hydrogel-forming polymeric substance(s), the liquid solvent will be an aqueous liquid solvent. In preferred forms, the hydrogelforming polymeric substance(s) and the aqueous liquid solvent will form an aqueous colloidal liquid coating medium, which may in some aspects help to limit the penetration of the liquid coating medium into the substrate and thereby help to modulate the distribution of the polymeric substance(s) relative to the substrate as discussed herein. The aqueous liquid solvent may for example be water, water mixed with one or more water-miscible organic solvents such as an alcohol (e.g. methanol) or ketone (e.g. acetone). In preferred forms, the liquid solvent of the coating medium will solvate the polymeric substance(s) of the coating medium. These and other liquid materials for use as solvents herein will be apparent to those skilled in the field. In addition, the polymeric substance(s) in the liquid coating medium may be present at any suitable concentration. Typically, the polymeric substance(s) of the coating medium, taken together when multiple polymeric substances are used, will be present at about 0.1% to about 20% by weight of the coating medium. In the case of liquid coating mediums including hydrogel-forming polymeric substance(s) in an aqueous liquid solvent, the hydrogel-forming polymeric substance(s), taken together when multiple hydrogelforming polymeric substances are used, will typically be present at about 0.5% to about 5% by weight of the coating medium. Generally, coated medical products as described herein can be provided sterile in a sterile barrier package, for example as illustrated in FIG. 22. As shown in FIG. 22, the sterile barrier package "P", which can for exampie be a single pouch or multiple pouch package, contains a coated medical product "CMP" as described herein, for example where product CMP is a product as depicted and discussed in conjunction with FIG. 8, FIG. 11, FIG. 13, FIG. 15, FIG. 17, FIG, 18, FIG. 19, FIG. 20, or FIG. 21. In some forms, the coated medical product CMP is terminally sterilized in the sterile barrier package P, for example by exposure to ethylene oxide gas or to sterilizing radiation.
[0124] The uses of the terms ”a" and "an" and "the” and similar references herein (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and ail examples, or exemplary language (e.g., "such as") provided herein, is intended merely to better illuminate embodiments of the disclosure and does not pose a limitation on the scope of the disclosure unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the products or methods defined by the claims.
[0125] While embodiments of the disclosure have been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only some embodiments have been shown and described and that all changes and modifications that come within the spirit of the disclosures herein are desired to be protected, in addition, all references cited herein are indicative of the level of skill in the art and are hereby incorporated by reference in their entirety.
Claims
CLAIMS1. A method for preparing a coated medical product, comprising: first applying a first liquid coating medium containing one or more polymeric substances to a first side surface of a porous sheet substrate so that the first liquid coating medium penetrates pores of the porous sheet substrate only partially through a thickness of the porous sheet substrate between the first side surface of the porous sheet substrate and a second side surface of the porous sheet substrate opposite the first side surface.; and first treating the first liquid coating medium to form a first coating including the one or more polymeric substances of the first liquid coating medium, the first coating providing amounts of the polymeric substance(s) of the first liquid coating medium external of the first side surface and penetrating only partially through the thickness of the porous sheet substrate, preferably wherein the first treating includes drying; second applying a second liquid coating medium containing one or more polymeric substances to the second side surface of the porous sheet substrate so that the second liquid coating medium penetrates pores of the porous sheet substrate only partially through the thickness of the porous sheet substrate; and second treating the second liquid coating medium to form a second coating including the one or more polymeric substances of the second liquid coating medium, the second coating providing amounts of the polymeric substance(s) of the second liquid coating medium external of the second side surface and penetrating only partially through the thickness of the porous sheet substrate, preferably wherein the second treating includes drying.
2. The method of claim 1, also comprising holding the porous sheet substrate in a flat condition during the first applying, first treating, second applying and second treating.
3. The method of claim 1 or 2, wherein during the first applying and first treating, the porous sheet substrate is held in a frame providing frame walls extending upwardly from the first side surface of the porous sheet substrate and defining a closed pool space above the first side surface of the substrate.
4. The method of any preceding ciaim, wherein during the second applying and second treating, the porous sheet substrate is held in a frame providing frame walls extending upwardly from the second side surface of the porous sheet substrate and defining a closed poo! space above the second side surface of the substrate.
5. The method of any preceding ciaim, wherein the first treating includes first drying, and second treating includes second drying, and wherein the first drying and the second drying are each conducted over a period of at least one hour.
6. The method of any preceding ciaim, wherein the first treating and second treating are conducted while exposing the first liquid coating medium and the second liquid coating medium, respectively, to a pressure at or above atmospheric pressure.
7. The method of any preceding ciaim, wherein a total concentration of the polymeric substance(s) in the first liquid coating medium is in the range of about 0.5% to about 5% by weight.
8. The method of any preceding claim, wherein the first applying, first treating, second applying, and second treating are conducted tinder conditions effective to provide the coated medical product having a wrinkle-free surface of the first coating and a wrinkle-free surface of the second coating.
9. The method of any preceding claim, also comprising, after the second treating, holding the porous sheet substrate in a flat condition in an atmosphere during a period of equilibration of a moisture content of the product with the atmosphere, and thereafter optionally cutting the porous sheet substrate having the first coating and second coating thereon to a shape.
10. The method of any preceding claim, wherein the first applying comprises dispensing a first volume of the first liquid coating medium onto the first side surface and allowing the first volume of the first liquid coating medium to seif level to gravity, and / or wherein the second applying comprises dispensing a second volume of the second liquid coating medium onto the second side surface and allowing the second volume of the second liquid coating medium to self level to gravity.
11. The method of any preceding claim, wherein the first liquid coating medium is an aqueous liquid medium and the second liquid coating medium is an aqueous liquid medium.
12. The method of any preceding ciaim, wherein the polymeric substance(s) of the first liquid coating medium include at least one hydrogel-forming polymer and / or wherein the polymeric substance(s) of the second liquid coating medium include at least one hydrogel-forming polymer.
13. The method of any preceding claim, wherein the porous sheet substrate is a multilaminate substrate.
14. The method of any preceding claim, wherein the porous sheet substrate includes at least one decellularized extracellular matrix tissue layer.
15. The method of claim 13, wherein the multilaminate substrate includes a laminate of a plurality of decellularized extracellular matrix tissue layers.
16. The method of any preceding claim, wherein at the initiation of the first applying, the porous sheet substrate is in dry condition.
17. The method of claim 16, wherein at the initiation of the first applying, the porous sheet substrate is a vacuum pressed porous sheet substrate.
18. The method of any preceding claim, wherein the first treating includes convection drying and / or wherein the second treating includes convection drying.
19. The method of any preceding claim, wherein the first coating provides amounts of the polymeric substance^} of the first liquid coating medium substantially completely covering the first side surface and / or wherein the second coating provides amounts of the polymeric substance(s) of the second liquid coating medium substantially completely covering the second side surface,20. The method of any preceding claim, wherein the polymeric substance(s) of the first liquid coating medium and the polymeric substance(s) of the second liquid coating medium include alginic acid or a salt thereof and hyaluronic acid or a salt thereof.
21. The method of any preceding claim, wherein the polymeric substance(s) of the first liquid coating medium include sodium alginate and sodium hyaluronate.
22. The method of any preceding ciaim, wherein (i) after said first treating at least 60% by dry weight of the polymeric substance(s) of the first coating occur overtop the first side surface of the substrate and / or (ii) after said second treating at least 60% by dry weight of the polymeric substance(s) of the second coating occur overtop the second side surface of the substrate,23. A coated medical product, comprising: a porous sheet substrate having a first side surface, a second side surface opposite the first side surface and a thickness between the first side surface and the second side surface; a first coating including one or more polymeric substances at the first side surface and penetrating oniy partially through the thickness of the porous sheet substrate; and a second coating including one or more polymeric substances at the second side surface and penetrating only partially through the thickness of the porous sheet substrate.
24. The product of claim 23, wherein the polymeric substance(s) of the first coating include at least one hydrogel-forming polymer and / or wherein the polymeric substance(s) of the second coating include at least one hydrogel-forming polymer.
25. The product of claim 23 or 24, wherein the porous sheet substrate is a multilaminate substrate.
26. The product of any one of claims 23 to 25, wherein the porous sheet substrate includes at least one decellularized extracellular matrix tissue layer.
27. The product of claim 25, wherein the multilaminate substrate includes a plurality of decellularized extracellular matrix tissue layers laminated together, optionally a total of two to ten decellularized extracellular tissue layers laminated together.
28. The product of any one of claims 23 to 27, in dried condition.
29. The product of claim 28, wherein upon wetting with an aqueous medium the porous sheet substrate tends to expand differentially to the first coating and / or the second coating thereby causing the product to deform absent externally applied force.
30. The product of any one of claims 23 to 29, wherein the porous sheet substrate is a vacuum pressed porous sheet substrate.
31. The product of any one of claims 23 to 30, wherein the first coating is a convection-dried coating and / or wherein the second coating is a convection- dried coating.
32. The product of any one of claims 23 to 31, wherein the first coating provides amounts of the polymeric substance(s) of the first coating substantially completely covering the first side surface and / or wherein the second coating provides amounts of the polymeric substaoce(s) of the second coating substantially completely covering the second side surface.
33. The product of any one of claims 23 to 32, having a product periphery defined by cut edges, the cut edges presenting exposed portions of the porous sheet substrate, the first coating, and the second coating.
34. The product of any one of claims 23 to 33, wherein the porous sheet substrate, the first coating, and second coating, are free of wrinkles.
35. The product of any one of claims 23 to 34, wherein the product, in a relaxed condition, is flat.
36. The product of any one of claims 23 to 35, wherein the first coating provides a first conformal outer layer of the polymeric substance(s) of the first coating positioned overtop and conforming to the first side surface.
37. The product of claim 36, wherein the first conformal outer layer is characterized as a deposit of amounts of the polymeric substance(s) of the first coating coalesced under drying conditions from a self-ieveied liquid medium including the polymeric substance(s) of the first coating.
38. The product of claim 37, wherein the drying conditions are at or above atmospheric pressure.
39. The product of claim 38, wherein the drying conditions are convection drying conditions.
40. The product of any one of claims 23 to 39, wherein the second coating provides a second conformal outer layer of the polymeric substance(s) of the second coating positioned overtop and conforming to the second outer surface.
41. The product of claim 40, wherein the second conformal outer Sayer is characterized as a deposit of amounts of the polymeric substance(s) of the second coating coalesced under drying conditions from a self-leveled liquid medium including the polymeric substance(s) of the second coating.
42. The product of claim 41, wherein the drying conditions are at or above atmospheric pressure.
43. The product of claim 42, wherein the drying conditions are convection drying conditions.
44. The product of any one of claims 23 to 43, wherein the polymeric substance(s) of the first coating and the polymeric substance(s) of the second coating are the same as each other.
45. The product of any one of claims 23 to 44, wherein the polymeric substance(s) of the first coating and the polymeric substance(s) of the second coating include at least one member selected from the group: polyvinyl pyrrolidones, polyvinyl alcohols, polyvinyl acetates, vinyl acetate esters, starches, dextrins, dextrans, carboxymethyl cellulose, carboxy methyl ethyl cellulose, hyaluronic acid, alginates, chondroitin sulfates, poly-lactides, gelatin, polyethylene glycols, poloxamers, and carbomers.
46. The product of claim 45, wherein the polymeric substance(s) of the first coating and the polymeric substance(s) of the second coating include at least two members selected from the group polyvinyl pyrrolidones, polyvinyl alcohols, polyvinyl acetates, vinyl acetate esters, starches, dextrins, dextrans, carboxymethyl cellulose, carboxy methyl ethyl cellulose, hyaluronic acid, alginates, chondroitin sulfates, poly-lactldes, gelatin, polyethylene glycols, poloxamers, and carbomers.
47. The product of any one of claims 23 to 46, wherein the polymeric substance(s) of the first coating and the polymeric substance(s) of the second coating each include a first polymeric substance and a second polymeric substance, wherein with the first coating and the second coating in a condition wetted by an aqueous medium include a matrix of the first polymeric substance entraining solvated amounts of the second polymeric matrix.
48. The product of any one of claims 23 to 47, wherein the polymeric substance{s) of the first coating and the polymeric substance(s) of the second coating each include alginic acid or a salt thereof and hyaluronic acid or a salt thereof, optionally wherein the polymeric substance(s) of the first coating and the polymeric substance(s) of the second coating each include sodium alginate and sodium hyaluronate.
49. The product of any one of claims 23 to 48, wherein (i) at least 60% by dry weight of the polymeric substance(s) of the first coating occur overtop the first side surface of the substrate and / or (ii) at least 60% by dry weight of the polymeric substance(s) of the second coating occur overtop the second side surface of the substrate.
50. The product of any one of claims 23 to 49, in sterile condition sealed within a steriie-barrier package.
51. A method for preparing a coated medical product, comprising: first applying a first liquid coating medium containing one or more polymeric substances to a first side surface of a flat, dried porous sheet substrate, so as to form a layer of the first liquid coating medium; and first drying the first liquid coating medium by exposure to a first drying atmosphere to form a first coating including the one or more polymeric substances of the first liquid coating medium, said first drying conducted while the porous sheet substrate is secured in a flat condition with a surface of the layer of the first liquid coating medium forming a liquid-gas interface directly with the first drying atmosphere.
52. The method of claim 51, also comprising: second applying a second liquid coating medium containing one or more polymeric substances to a second side surface of a fiat, dried porous sheet substrate opposite the first side surface, so as to form a layer of the second liquid coating medium; and second drying the second liquid coating medium by exposure to a second drying atmosphere to form a second coating including the one or more polymeric substances of the second liquid coating medium, said second dryingconducted while the porous sheet substrate is secured in a flat condition with a surface of the layer of the second liquid coating medium forming a liquid-gas interface directly with the drying atmosphere.
53. The method of claim 51 or 52, wherein during the first applying and first drying, the porous sheet substrate is held in a frame providing frame walls extending upwardly from the first side surface of the porous sheet substrate and defining a closed pool space above the first side surface of the substrate.
54. The method of any one of claims 51 to 53, wherein during the second applying and second drying, the porous sheet substrate is held in a frame providing frame walls extending upwardly from the second side surface of the porous sheet substrate and defining a closed pool space above the second side surface of the substrate.
55. The method of any one of ciaims 51 to 54, wherein the first drying and the second drying are each conducted over a period of at least one hour.
56. The method of any one of claims 51 to 55, wherein the first drying atmosphere and the second drying atmosphere are at a pressure at or above atmospheric pressure.
57. The method of any one of claims 51 to 56, wherein a total concentration of the polymeric substancefs) in the first liquid coating medium is in the range of about 0.5% to about 5% by weight, and when present the total concentration of the polymeric substances in the second liquid coating medium is in the range of about 0.5% to about 5% by weight.
58. The method of any one of claims 51 to 57, wherein the first applying and first drying, and when present the second applying and second drying, are conducted under conditions effective to provide the coated medical product in a substantially wrinkle-free condition.
59. The method of any one of claims 51 to 58, also comprising, after the second drying, holding the porous sheet substrate in a flat condition in an atmosphere during a period of equilibration of a moisture content of the product with the atmosphere, and thereafter optionally cutting the porous sheet substrate having the first coating and second coating thereon to a shape.
60. The method of any one of claims 51 to 59, wherein the first applying comprises dispensing a first volume of the first liquid coating medium onto the first side surface and allowing the first volume of the first liquid coating medium to self level to gravity, and / or when present the second applying comprises dispensing a second volume of the second liquid coating medium onto the second side surface and allowing the second volume of the second liquid coating medium to self level to gravity.
61. The method of any one of claims 51 to 60, wherein the first liquid coating medium is an aqueous liquid medium and the second liquid coating medium is an aqueous liquid medium.
62. The method of any one of claims 51 to 61, wherein the polymeric substance(s) of the first liquid coating medium include at least one hydrogel-forming polymer and / or wherein when present the polymeric substance(s) of the second liquid coating medium include at least one hydrogel-forming polymer,S3. The method of any one of claims 51 to 62, wherein the porous sheet substrate is a multilaminate substrate.
64. The method of any one of claims 51 to 63, wherein the porous sheet substrate includes at least one decellularized extracellular matrix tissue layer.
65. The method of claim 64, wherein the multilaminate substrate includes a plurality of decellularized extracellular matrix tissue layers laminated together, optionally a total of two to ten decellularized extracellular matrix tissue layers laminated together.
66. The method of any one of claims 51 to 65, wherein at the initiation of the first applying, the porous sheet substrate is in dry condition.
67. The method of claim 66, wherein at the initiation of the first applying, the porous sheet substrate is a vacuum pressed porous sheet substrate.
68. The method of any one of claims 51 to 67, wherein the first drying atmosphere is or includes a convection drying atmosphere and / or wherein when present the second drying atmosphere is or includes a convection drying atmosphere.
69. The method of any one of claims 51 to 68, wherein the first coating provides amounts of the polymeric substance(s) of the first liquid coating mediumsubstantially completely covering the first side surface and / or wherein when present the second coating provides amounts of the polymeric substance(s) of the second liquid coating medium substantially completely covering the second side surface.
70. The method of any one of claims 51 to 69, wherein after the first drying at least 60% by dry weight of the polymeric substance(s) of the first coating occur overtop the first side surface of the substrate.
71. The method of any one of claims 51 to 70, wherein the polymeric substance(s) of the first coating include alginic acid or a salt thereof and hyaluronic acid or a salt thereof, optionally wherein the polymeric substance(s) of the first coating include sodium alginate and sodium hyaluronate.
72. The method of any one of claims 51 to 71, wherein the substrate relaxes In response to the first applying and shrinks in response to the first drying.
73. A coated medical product, comprising: a porous sheet substrate having a first side surface, a second side surface opposite the first side surface, and a thickness extending from the first side surface to the second side surface; a first coating including one or more polymeric substances on the first side surface; a second coating including one or more polymeric substances on the second side surface, wherein the second coating and the first coating are not segments of a single, uniform coating formed on the porous sheet substrate; and said coated medical product, absent externally applied force, being in a flat condition with said first coating and said second coating being wrinkle-free.
74. The product of claim 73, wherein the polymeric substance(s} of the first coating include at least one hydrogel-forming polymer and / or wherein the polymeric substance(s) of the second coating include at least one hydrogel-forming polymer.
75. The product of ciaim 73 or 74, wherein the porous sheet substrate is a multi lam inate substrate.
76. The product of any one of claims 73 to 7S, wherein the porous sheet substrate includes at least one decellularized extracellular matrix tissue layer.
77. The product of claim 76, wherein the multilaminate substrate includes a plurality of decellularized extracellular matrix tissue layers laminated together, optionally a total of two to ten decellularized extracellular tissue layers laminated together.
78. The product of any one of claims 73 to 77, including a stratum of the porous sheet substrate intermediate the first coating and the second coating and that is free of the polymeric substance(s) of both the first coating and the second coating.
79. The product of any one of claims 73 to 78, wherein the first coating is a dried first coating and the second coating is a dried second coating.
80. The product of any one of claims 73 to 79, wherein the porous sheet substrate is a vacuum pressed porous sheet substrate.
81. The product of any one of claims 73 to 80, wherein the first coating Is a convection-dried coating and / or wherein the second coating is a convection- dried coating.
82. The product of any one of claims 73 to 81, wherein the first coating provides amounts of the polymeric substance(s) of the first coating substantially completely covering the first side surface and / or wherein the second coating provides amounts of the polymeric substance(s) of the second coating substantially completely covering the second side surface.
83. The product of any one of claims 73 to 82, having a product periphery defined by cut edges, the cut edges presenting exposed portions of the porous sheet substrate, the first coating, and the second coating.
84. The product of any one of claims 73 to 83, wherein the first coating provides a first conformal outer layer of the polymeric substance(s) of the first coating positioned overtop and conforming to the first side surface.
85. The product of claim 84, wherein the first conformal outer layer is characterized as a deposit of amounts of the polymeric substance(s) of the first coating coalesced under first drying conditions from a self-leveled liquid medium including the polymeric substance(s) of the first coating.
86. The product of claim 85, wherein the first drying conditions are at or above atmospheric pressure.
87. The product of claim 85 or 86, wherein the first drying conditions are convection drying conditions.
88. The product of any one of claims 73 to 87, wherein the second coating provides a second conformal outer layer of the polymeric substance(s) of the second coating positioned overtop and conforming to the second outer surface.
89. The product of claim 88, wherein the second conformal outer iayer is characterized as a deposit of amounts of the polymeric substance(s) of the second coating coalesced under second drying conditions from a self-leveled liquid medium including the polymeric substance(s) of the second coating.
90. The product of claim 89, wherein the second drying conditions are at or above atmospheric pressure.
91. The product of claim 89 or 90, wherein the second drying conditions are convection drying conditions.
92. The product of any one of claims 73 to 91, wherein the polymeric substance(s) of the first coating and the polymeric substance(s) of the second coating are the same as each other.
93. The product of any one of claims 73 to 92, wherein the polymeric substance(s) of the first coating and the polymeric substance(s) of the second coating include at least one member selected from the group: polyvinyl pyrrolidones, polyvinyl alcohols, polyvinyl acetates, vinyl acetate esters, starches, dextrins, dextrans, carboxymethyl celluloses, carboxy methyl ethyl celluloses, hyaluronic acids, alginates, chondroitin sulfates, poly-lactides, gelatins, caseins, polyethylene glycol, poloxamers, and carbomers.
94. The product of claim 93, wherein the poly meric substance(s) of the first coating and the polymeric substance(s) of the second coating include at least two members selected from the group: polyvinyl pyrrolidones, polyvinyl alcohols, polyvinyl acetates, vinyl acetate esters, starches, dextrins, dextrans, carboxymethyl celluloses, carboxy methyl ethyl celluloses, hyaluronic acids,alginates, chondroitin sulfates, poly-lactides, gelatins, caseins, polyethylene glycol, poloxamers, and carbomers.
95. The product of any one of claims 73 to 94, wherein the polymeric substance(s) of the first coating and the polymeric substance(s) of the second coating each include a first polymeric substance and a second polymeric substance, wherein with the first coating and the second coating in a condition wetted by an aqueous medium include a matrix of the first polymeric substance entraining solvated amounts of the second polymeric substance.
96. The product of any one of claims 73 to 95, wherein the polymeric substance{s) of the first coating and the polymeric substance(s) of the second coating each include alginic acid or a salt thereof and hyaluronic acid or a salt thereof, optionally wherein the polymeric substance(s) of the first coating and the polymeric substance(s) of the second coating each include sodium aiginate and sodium hyaluronate,97. The product of any one of claims 73 to 95, wherein at least 60% by dry weight of the polymeric substance(s) of the first coating occur overtop the first side surface of the substrate and / or at least 60% by dry weight of the polymeric substance(s) of the second coating occur overtop the second side surface of the substrate,98. The product of any one of claims 73 to 97, in sterile condition sealed within a sterile-barrier package.
99. The product of claim 98, which has been terminally sterilized within the package by exposure to a humidified atmosphere including ethylene oxide.
100. A method for preparing a shaped, coated medical product, comprising: providing a coated medical product including a porous sheet substrate and a first coating containing one or more polymeric substances; reshaping the coated medical product from a first shape to a second shape different from the first shape; moistening the coated medical product; and drying the coated medical product to remove liquid added during said moistening while holding the coated medical product in the second shape,so as to reset a shape memory of the coated medical product from the first shape to a reset shape different from the first shape,101. The method of claim 100, wherein said moistening includes exposing the coated medical product to a gaseous atmosphere including a vapor of a moistening liquid,102. The method of claim 101, wherein the moistening liquid is water.
103. The method of any one of claims 100 to 102, wherein the reset shape is substantially said second shape,104. The method of any one of claims 100 to 102, wherein the one or more polymeric substances includes a hydrogel-forming polymer;105. The method of any one of claims 100 to 104, wherein said first shape is a fiat shape.
106. The method of any one of claims 100 to 105, wherein the second shape is a curled shape,107. The method of any one of claims 100 to 106, wherein the coated medical product further includes a second coating.
108. The method of any one of claims 100 to 107, wherein the first coating has amounts of the polymeric substance(s) of the first coating at a first side surface of the porous sheet substrate and penetrating only partially through a thickness of the porous sheet substrate.
109. The method of claim 108, wherein the first coating provides a first conformal outer layer of the polymeric substance(s) of the first coating positioned overtop and conforming to the first side surface110. The method of claim 107, wherein the first coating has amounts of the polymeric substance(s) of the first coating at a first side surface of the porous sheet substrate and penetrating only partially through a thickness of the porous sheet substrate, and wherein the second coating has amounts of polymeric substance(s) of the second coating at a second side surface of the porous sheet substrate opposite the first side surface and penetrating only partially through the thickness of the porous sheet substrate.
111. The method of claim 110, wherein the first coating provides a first conformal outer layer of the polymeric substance(s) of the first coating positioned overtop and conforming to the first side surface, and wherein the second coating provides a second conformal outer layer of the polymeric substance(s) of the second coating positioned overtop and conforming to the second side surface.
112. The method of any one of claims 100 to 111, wherein the porous sheet substrate includes at least one decellularized extracellular matrix layer.
113. The method of any one of claims 100 to 112, wherein the porous sheet substrate is or includes a multilaminate porous sheet substrate including a plurality of decellularized extracellular matrix layers laminated together.
114. The method of any one of claims 100 to 113, also comprising, after said drying, exposing the coated medical product to an atmosphere to equilibrate a moisture content of the product to the atmosphere while holding the product in the second shape.
115. The method of any one of claims 100 to 114, wherein the polymeric substance(s) of the first coating include alginic acid or a salt thereof and hyaluronic acid or a salt thereof, optionally wherein the polymeric substance(s) of the first coating include sodium alginate and sodium hyaluronate.
116. A shaped, coated medical product, comprising: a porous sheet substrate imparted with shape memory for a shape other than a flat shape; a first coating on the porous sheet substrate, the first coating including one or more polymeric substances; the first coating providing a first conformai outer layer of the polymeric substance(s) of the first coating positioned overtop and conforming to a first side surface of the porous sheet substrate.
117. The product of claim 116, wherein the first coating has first coating surface, and wherein the first coating surface is wrinkle free.
118. The product of claim 116 or 117, wherein the first conformal outer layer is characterized as a deposit of amounts of the polymeric substance(s) of the first coating coalesced under first drying conditions from a self-leveled liquid coating medium including the polymeric substance(s) of the first coating.
119. The product of any one of claims 116 to 118, wherein the one or more polymeric substances includes a hydrogel -forming polymeric substance.
120. The product of any one of claims 116 to 119, wherein said shape other than a flat shape is a curled shape.
121. The product of any one of claims 116 to 120, wherein the coated medical product further includes a second coating.
122. The product of any one of claims 116 to 121, wherein the first coating also provides amounts of the polymeric substance(s) of the first coating penetrating only partially through a thickness of the porous sheet substrate.
123. The product of claim 121, wherein the first coating also provides amounts of the polymeric substance(s) of the first coating penetrating only partially through a thickness of the porous sheet substrate, and wherein the second coating provides a second conformal outer layer of amounts of polymeric substance(s) of the second coating positioned overtop and conforming to a second side surface of the porous sheet substrate and amounts of polymeric substancefs) of the second coating penetrating only partially through the thickness of the porous sheet substrate.
124. The product of any one of claims 116 to 123, wherein the porous sheet substrate includes at least one decellularized extracellular matrix layer.
125. The product of any one of claims 116 to 124, wherein the porous sheet substrate is or includes a multilaminate porous sheet substrate including a plurality of decellularized extracellular matrix layers laminated together.
126. A coated medical product, comprising: a porous sheet substrate having a first side surface, a second side surface opposite the first side surface, and a thickness extending from the first side surface to the second side surface;a first coating including one or more polymeric substances, the first coating providing amounts of the one or more polymeric substances external of the first side surface; wherein the first coating becomes lubricious on wetting with water; and wherein the first coating:(i) penetrates only partially through the thickness of the substrate; and / or(ii) has a first coating surface that is contoured to the first side surface of the substrate; and / or(iii) has a first coating surface formed by self-coalescing of the polymeric substance(s) during drying of a liquid coating medium including the polymeric substance(s) while horizontal to gravity; and / or(iv) has at least 60% by dry weight, or optionally at least 70% by dry weight, of the polymeric substance(s) of the first coating occurring overtop the first side surface of the substrate.
127. The product of claim 126, wherein the first coating penetrates only partially through the thickness of the substrate.
128. The product of claim 126 or 127, wherein the first coating has a first coating surface that is contoured to the first side surface of the substrate.
129. The product of any one of claims 126 to 128, wherein the first coating has a first coating surface formed by self-coalescing of the polymeric substance(s) during drying of a liquid coating medium including the polymeric substance(s) while horizontal to gravity.
130. The product of any one of claims 126 to 128, wherein the first coating has at least 60% by dry weight, or at least 70% by dry weight, of the polymeric substance(s) of the first coating occurring overtop the first side surface of the substrate.
131. The product of any one of claims 126 to 130, wherein the polymeric substance(s) of the first coating include at least one hydrogel-forming polymer.
132. The product of any one of ciaims 126 to 131, wherein the porous sheet substrate includes at least one decellularized extracellular matrix tissue layer,133. The product of claim 132, wherein the porous sheet substrate is a multi laminate substrate that includes a plurality of decellularized extracellular matrix tissue layers laminated together, optionally a total of two to ten decellularized extracellular tissue layers laminated together.
134. The product of any one of claims 126 to 133, wherein the porous sheet substrate is a vacuum pressed porous sheet substrate.
135. The product of any one of claims 126 to 134, wherein the first coating is a convection-dried coating.
136. The product of any one of claims 126 to 135, wherein the first coating provides amounts of the polymeric substance(s) of the first coating substantially completely covering the first side surface.
137. The product of any one of claims 126 to 135, having a product periphery defined by cut edges, the cut edges presenting exposed portions of the porous sheet substrate and the dried the first coating.
138. The product of any one of claims 126 to 137, wherein the first coating provides a first conformal outer layer of the polymeric substance(s) of the first coating positioned overtop and conforming to the first side surface.
139. The product of claim 138, wherein the first conformal outer layer is characterized as a deposit of amounts of the polymeric substance(s) of the first coating coalesced under first drying conditions from a self-leveled liquid coating medium including the polymeric substance(s) of the dried first coating.
140. The product of claim 139, wherein the first drying conditions are at or above atmospheric pressure.
141. The product of claim 139 or 140, wherein the first drying conditions are convection drying conditions.
142. The product of any one of claims 1.26 to 141, also comprising a second coating including one or more polymeric substances on the second side surface.
143. The product of claim 142, wherein the second coating provides a conformal outer layer of the polymeric substance(s) of the second coating positioned overtop and conforming to the second outer surface.
144. The product of claim 143, wherein the second conformal outer layer is characterized as a deposit of amounts of the polymeric substance(s) of the second coating coalesced under second drying conditions from a self-leveled liquid medium including the polymeric substance(s) of the second coating.
145. The product of claim 144, wherein the second drying conditions are at or above atmospheric pressure.
146. The product of claim 144 or 145, wherein the second drying conditions are convection drying conditions.
147. The product of any one of claims 142 to 146, wherein the polymeric substance(s) of the first coating and the polymeric substance(s) of the second coating are the same as each other.
148. The product of any one of claims 126 to 147, wherein the polymeric substance(s) of the first coating include at least one member selected from the group: polyvinyl pyrrolidones, polyvinyl alcohols, polyvinyl acetates, vinyl acetate esters, starches, dextrins, dextrans, carboxymethyl celluloses, carboxy methyl ethyl celluloses, hyaluronic acids, alginates, chondroitin sulfates, poly-lactides, gelatins, caseins, polyethylene glycol, poloxamers, and carbomers.
149. The product of claim 148, wherein the polymeric substance(s) of the first coating include at least two members selected from the group: polyvinyl pyrrolidones, polyvinyl alcohols, polyvinyl acetates, vinyl acetate esters, starches, dextrins, dextrans, carboxymethyl celluloses, carboxy methyl ethyl celluloses, hyaluronic acids, alginates, chondroitin sulfates, poly-lactides, gelatins, caseins, polyethylene glycol, poloxamers, and carbomers.
150. The product of any one of claims 126 to 149, wherein the polymeric substance(s) of the first coating include a first polymeric substance and a second polymeric substance, wherein the first coating when wetted by an aqueous medium includes a matrix of the first polymeric substance entraining solvated amounts of the second polymeric substance.
151. The product of any one of claims 126 to 150, wherein at least 70% by dry weight of the polymeric substance(s) of the first coating occur overtop the first side surface of the substrate.
152. The product of any one of claims 126 to 151, wherein the polymeric substance(s) of the first coating include alginic acid or a salt thereof and hyaluronic acid or a salt thereof, optionally wherein the polymeric substance(s) of the first coating include sodium alginate and sodium hyaluronate.
153. A coated medical product, comprising: a porous sheet substrate including a plurality of layers of decellularized extracellular matrix material laminated together, the substrate having a first side surface, a second side surface, and a thickness occurring between the first side surface and the second side surface; polymeric coating material carried by the porous sheet substrate, the polymeric coating material including a plurality of polymeric substances in admixture, the plurality of polymeric substances including at least two hydrogelforming polymeric substances; the polymeric coating material including an internalized coating material portion positioned within the porous sheet substrate and an externalized coating material portion positioned external of the porous sheet substrate; and wherein the externalized coating material portion includes at least 60% by dry weight of the plurality of polymeric substances of the polymeric coating material.
154. The product of claim 153, wherein the at least two hydrogel-forming polymeric substances includes hyaluronic acid or a salt thereof.
155. The product of claim 153 or 154, wherein the at least two hydrogel -forming polymeric substances includes alginic acid or a salt thereof.
156. The product of any one of claims 153 to 155, wherein the extracellular matrix material is vacuum pressed extracellular matrix material.
157. The product of any one of claims 153 to 156, wherein the externalized coating material portion forms a conformal layer of the polymeric substancespositioned overtop only the first side surface., only the second side surface, or both the first side surface and the second side surface,158. The product of any one of claims 153 to 157, wherein the externalized coating material portion is characterized as molecules of the polymeric substances self-coalesced under the force of gravity during drying of a liquid coating medium including the polymeric substances,159. The product of any one of claims 153 to 157, wherein the externalized coating portion has an outer coating surface contoured to at least one of, or both of, the first side surface and the second side surface of the porous sheet substrate,160. The product of any one of claims 153 to 159, wherein a first layer of the plurality of layers of decellularized extracellular matrix material provides the first side surface and a second layer of the plurality of layers of extracellular matrix provides the second side surface,161. The product of any one of claims 153 to 160, wherein the layers of decellularized extracellular matrix material are layers of a decellularized submucosa-containing extracellular matrix material.
162. The product of any one of claims 153 to 161, having only two to ten of the layers of decellularized extracellular matrix material.
163. The product of any one of claims 153 to 162, wherein the polymeric coating material includes a first coating and a second coating applied separately from the first coating,164. The product of claim 163, wherein the first coating is applied to the first side of the substrate and the second coating is applied to the second side of the substrate,165. The product of claim 163 or 164, wherein the first coating and the second coating contain the same polymeric substances as one another.
166. The product of any one of claims 163 to 165, wherein the first coating and the second coating each penetrate only partially through the thickness of the substrate.
167. The product of any one of claims 153 to 166, wherein the substrate has a flat shape.
168. The product of any one of claims 153 to 167, wherein the substrate has a non-flat shape.
169. The product of claim 168, wherein the substrate has a curled shape.
170. The product of claim 169, wherein the curled shape has walls that curve circumferentially greater than about 270 degrees but no more than about 450 degrees.
171. The product of claim 169 or 170, wherein the curled shape has walis that curve circumferentially less than 360 degrees and presents non-overlapped edges of the porous sheet substrate.
172. The product of claim 169 or 170, wherein the curled shape has walls that curve circumferentially greater than 360 degrees and presents overlapped edges of the porous sheet substrate.
173. The product of any one of claims 153 to 172, wherein the polymeric coating material is wrinkle free.
Citation Information
Patent Citations
Absorbable adhesives and their formulation for use in medical applications
US10500309B2
Drug eluting graft constructs and methods
US11065368B2
Neural regeneration conduit
US20010031974A1
Implantable materials and methods for inhibiting tissue adhesion formation
US20060251702A1
Analgesic coated medical product
US20090142400A1
